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Abstract
The work in this thesis is split into two parts. The introduction and following two chapters
pertain to the investigation of gene regulation using Chip-seq data and linear modelling. The
final chapter pertains to the prediction of hot-spot residues in protein-protein interactions.
The rapid escalation in the speed and quality of DNA sequencing has lead to a wealth
of data for the location of transcription factor binding and histone modifications across the
genomes. Using Chromatin ImmunoPrecipitation followed by sequencing (ChIP-seq) data, we
have generated a new binding metric based on the enrichment of the read-counts for each
gene.
Eight datasets from mouse macrophage cells (two histone modifications, five transcription
factors, DNase I hypersensitivity) were used to model the binding of RNA polymerase II. It was
found that a linear model just using the DNase I hypersensitivity and histone modification data
was better than any of the models containing the transcription factor data. Investigation of the
outlying genes for the model revealed no pattern in their Gene Ontology terms or macrophage-
specific genes.
Human embryonic stem cell data (23 transcription factor and 24 histone modification datasets)
were used in combination with LASSO regression to model the binding of RNA polymerase II.
The resultant models contrasted with the results from the mouse macrophage linear models in
that using the histone modifications data in combination with the transcription factor data lead
to the best models. A much more complicated picture of the regulation of RNA polymerase II
binding was produced using the LASSO models.
Protein-protein interactions are essential for every function within a cell and being able to
predict them has large consequences for drug discovery and understanding the vast protein-
interaction networks that occur within cells. Predicting protein-protein interactions is difficult
due to the large number of possible conformations; predicting hot-spot residues can greatly
reduce this. InterBasePro was compared with experimental data and subsequently adaptation
was done to assess its usefulness for predicting hot-spot residues. An alternative approach
was also made into classifying hot-spot residues based on atomic contacts.
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Chapter 1
Introduction
1
This thesis describes two different projects. This introduction and first two chapters are
centered around using high-throughput DNA sequencing data to model genetic regulation with
the aim of investigating a mechanistic hypothesis for RNA polymerase II binding. The final
chapter, with its own self-contained introduction, centers around the prediction of hot-spot
residues in protein-protein interfaces.
1.1 The Genome and Transcription
1.1.1 Organisation of DNA
Human DNA from a single cell is comprised of about 3 billion bases. If stretched out, this would
be over 2 meters long. Without being highly organised this would, quite simply, not fit into the
nucleus of every cell. The double-helical strand of DNA is first organised by being wrapped
around a histone protein complex. This complex is made up of 8 proteins, two H2A histone
proteins, two H2B histone proteins, two H3 histone proteins and two H4 histone proteins. Each
histone protein complex has about 200 base pairs of DNA wrapped around it. The coiling of
DNA around the histones reduces about 680Å of DNA into a 55Å by 110Å cylinder.1 This is
the first stage of the packing of DNA and is known as a nucleosome. The nucleosomes are
linked together by the H1 histone protein. This pulls the complexes closer together where they
form an incredibly dense coil. In metaphase, the stage of mitosis where the cell is splitting into
two and the majority of the DNA is inactive and tightly packed, with a total chromosomal length
of approximately 200µm. This is a packing ratio of 104. As incredible as this organisation is,
the tight packing of the nucelosomes and the coiling of the DNA around the histone complexes
means that the DNA cannot be easily bound by proteins or other mechanisms needed for it to
be transcribed to RNA.1
1.1.2 Histones
Histone proteins are the core of the organisation of DNA. Histones all have a high ratio of pos-
itively charged amino-acid residues; approximately one in four residues are arginine or lysine.
This high ratio of positively charged residues allows the histones to bind well to the negatively
charged phosphate backbone of the DNA strands. The essential function of these proteins
means that they are incredibly highly conserved. The H3 and H4 histones are the slowest
evolving of all eukaryotic genes.2 Interestingly, the H3 histones present within centromeres
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have a highly conserved core across many species but also have a massively divergent N-
terminal tail.3
Histone proteins are highly toxic to cells and as such their expression is tightly controlled.
Problems arise during mitosis, however, as DNA is duplicated at a massive rate, during which
a large amount of histone proteins are rapidly needed to pack and regulate the newly-produced
DNA. The regulation of histone protein transcription is still poorly understood. Interestingly, it
is thought that there are potentially two master regulators of histone genes, E2f1 and E2f4.4 It
was also found that there are specific regulators for the core (CTCF) and linker (Zfx) histones
as well as cell-type specific regulators.4
Histone Modifications
Histone modifications are essential in several ways for controlling the transcription of DNA.
They control how tightly the DNA helix is associated with the histone complex, and they can
have a direct effect on the binding ability of transcription factors and the transcription initiation
complex.
Acetylation of lysine in histones is generally associated with the activation of transcription.
Acetylation, by histone acetylation transferases, of the histone leads to a reduction in the pos-
itive charge of the histone. This means that the negatively charged DNA is less-tightly asso-
ciated with the histone complex, making it more accessible for transcription.5 De-acetylation,
by histone deacetylases, can also be employed by signalling pathways as a repressor of tran-
scription as they increase the binding of the DNA to the histone protein complex.6
Methylation of lysine and arginine residues in the histone proteins has a wide variety of
functions from large-scale re-modelling to activation and repression. H3K4 methylation is cor-
related with transcription of a gene. H3K4 mono-methylation normally peaks near the end of
the transcribed region, while H3K4 di-methylation peaks near the center of the transcribed re-
gion and H3K4 tri-methylation forms a sharp peak near the transcription start site.7 While H3K4
is correlated with transcription, the exact mechanisms by which H3K4 methylation encourages
transcription are not fully known.8;9 Unlike histone acetyltransferases and histone deactylases,
lysine methyltransferases are normally specific to a single lysine residue on a single histone.10
H3K36 and H3K79 methylation have both also been associated with transcriptional activation.
Methylation of H3K9, H3K27 and H4K20 are associated with repression of transcription. The
exact mechanisms of repression by histone methylation are not clear for all markers, but H3K36
methylation is known to recruit histone deactylases. The deactylation of the histone complex
results in a lower propensity for the associated DNA to be transcribed.11;12 While methylation
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of some lysine residues is used to repress transcription of genes, the demethylation is also
used as a process of activating transcription. LSD1 demethylation of H3K9 has been shown
to lead to transcription of the associated gene.13
The overall picture of histone modifications is under intense investigation. The simple pic-
ture outlined here is by no means comprehensive. The intricate interplay between the vast
array of histone modifications cannot identified using the current detection methods. High-
throughput techniques can only identify the presence of a single modification at a time and
do not identify the vast array of markers that are all potentially present on a single histone
complex.
1.1.3 Transcription
Transcription, the process of decoding the sequence of DNA bases in an RNA molecule, is the
first step in the production of proteins. Transcription is a highly regulated process which can
be split into five separate steps: pre-initiation, initiation, promoter clearance, elongation and
termination. The key protein complex responsible for transcription is RNA polymerase II. The
RNA polymerase II complex is responsible for the recruitment of appropriate RNA molecules
to the DNA sequence. There are three types of RNA polymerase enzymes: RNA polymerase
I, II and III. RNA polymerase I is responsible for the production of 18S, 5.8S and 28S ribosomal
RNA molecules. RNA polymerase III is responsible for the production of 5S ribosomal RNA
and of recruiting the correct amino acid during translation. RNA polymerase II is responsible
for transcribing the mRNA molecules which for encode proteins and for other RNA molecules,
such as snRNA.
Pre-initiation and initiation
Pre-initiation is the first stage of transcription and involves the binding of general transcription
factors to the promoter of the gene. In eukaryotes, one of the most understood core promoter
elements for genes is the TATA-box that resides 10 to 25 base pairs upstream from the tran-
scription start site. The pre-initiation stage involves the binding of the transcription factor II D
(TFIID) protein complex, which includes the TATA-binding protein (TBP). When TBP is bound,
the DNA bends to an angle of 80◦ towards the major groove, optimising the orientation of the
DNA for the binding of TFIID.14 The pre-initiation stage is highly controlled and continues with
the binding of a protein complex centered around TFIID.15 After TFIID has bound to the TATA-
box, TFIIA binds to the upstream edge of TFIID and TFIIB binds to the downstream edge of
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TFIID (see figure 1.1). The binding of TFIIB recruits the RNA polymerase II complex to the DNA
and the location of this determines the exact start site of transcription, as well as the direction
of transcription.16–19 TFIIF is recruited at this stage and causes a conformational change in the
initiation complex. This conformational change stabilises the complex and causes the DNA to
wrap around the RNA polymerase II complex. TFIIE then binds to the downstream edge of
RNA polymerase II and enhances the association of RNA polymerase II to TFIIB.20–22 The
binding of TFIIE promotes RNA polymerase II to begin separating the DNA strand and recruits
TFIIH to the pre-initiation complex. TFIIH is the final part of the pre-initiation complex and has
two functions; and ATP-helicase and kinase activity. TFIIH is essential for opening the DNA
and initiating transcription.23–25
With the binding of TFIIH, with its helicase and kinase functions, transcription can be ini-
tiated. The helicase function of TFIIH unwinds the DNA so that a single strand is accessible
to the RNA polymerase II. The RNA polymerase II complex then moves off from the promoter
region, leaving TFIIA and TFIID on the promoter.
The TATA-box is not the only core promoter element that can be present. The initiator
promoter element (INR, facilitates the binding of TFIID) can be present on or next to the tran-
scription start site, the TFIIB recognition element (BRE, facilitates the binding of TFIIB) may
be present adjacent to the TATA-box and the downstream promoter element (DPE) may be
present 30 bases downstream from the transcription start site.
Not all genes have a TATA-box for the pre-initiation complex to bind to. Genome wide
studies have shown how little is known about these promoter motifs. Only 10% of human
promoters were found to have a canonical TATA-box and 25% to have a TATA-like motif.26;27
Only 46% of human promoters were found to have a INR-motif with 30% of the total number
of promoters having INR-motifs but lacking a TATA-like motif.27 TATA-binding protein, when not
associated with TFIID, is highly specific for the TATAA motif. When TATA-binding protein is
bound to TFIID, however, TFIID loses this specificity.28–30 TFIID binding is still required for the
initiation of transcription, regardless of the presence of a TATA motif.20 There is still much work
to be done in identifying promoter motifs and the vast amount of data produced by the current
generation of sequencing methods is helping to identify new motifs.27;31
Promoter clearance, elongation and termination
After the RNA polymerase and transcription factor binding complex has associated to the DNA,
RNA polymerase II has to get clear of the promoter before it can begin transcribing the DNA to
RNA. Initially RNA polymerase II will go through a phase of “abortive transcription”; a process
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Figure 1.1: The first stages of transcription 1: TBP is recruited to the promoter region, changing
the conformation of the DNA and allowing TFIID to bind. 2: The general transcription factors
and RNA polymerase II (RNAPII) are recruited by TFIID to the promoter complex. 3: TFIIH
uncoils the DNA allowing RNA polymerase II to bind fully and access the coding strand of
DNA. 4: The majority of the general transcription factors disassociate and RNA polymerase II
moves from the promoter region. TFIID remains bound to recruit more general transcription
factors and repeat the cycle. TAF: TBP-Associated Factor. Figure modified from Nicolas et
al 14
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where the first 2-15 bases are transcribed but then the RNA is released and the transcription
complex dissociates from the DNA or returns to the promoter.32 This continues until TFIIH
phosphorylates serine-5 of RNA polymerase II, allowing it to progress past the promoter re-
gion.33 Once elongation is established, RNA polymerase II unwinds the DNA by two turns of
the helix. Methylation of lysine 36 of the H3 histone protein is essential for the progression of
RNA polymerase II. As the RNA is transcribed, a 12bp of RNA-DNA hybrid with just under two
turns of the DNA helix. There is a sharp kink in the RNA at the end of this DNA-RNA hybrid he-
lix to ensure the RNA does not interfere with the two DNA strands as they re-associate. Once
the RNA strand reaches a length of 25 nucleotides, the transcription factors that were originally
needed for the recruitment of RNA polymerase II dissociate leaving the RNA polymerase II to
carry on transcribing the DNA. At this point the RNA molecule being synthesised is capped.
The cap is a tri-phosphorylated guanine nucleotide that defies the canonical 5’-3’ phosphate
link of normal nucleotides in that it forms a 5’-5’ tri-phosphate link. Capping is essential for
the formation of mature RNA; without the cap the RNA is susceptible to 5’ endonucleases and
degraded.
The process of transcription is a re-iterative process. The transcription complex moves
along the DNA one base at a time. The appropriate base-matching nucleotide is recruited
to the active site of the complex and a condensation reaction, catalysed by two magnesium
cations, results in the extension of the RNA molecule by one base and the release of pyrophos-
phate. Translocation moves the transcription complex forward a single base to re-expose the
active site and the process continues. The 12bp DNA-RNA hybrid is always maintained at the
same length; when a base is added to the 3’ end of the RNA molecule a base dissociates
from the DNA at the 5’ end. The mechanism that limits movement of the transcription factor
complex by a single base each step is still unknown and currently has not been successfully
modelled using molecular dynamics.34 The transcription complex is able to move backwards a
single base along the DNA. This generally occurs when an incorrect base is incorporated into
the RNA so that it can be removed.
Termination of transcription is as controlled as the previous stages and is a dynamic pro-
cess. Poly(A)-dependent termination requires a 5‘-AAUAAA-3‘ RNA sequence followed by a
G/U rich sequence being transcribed. Upon the AAUAAA sequence leaving the transcription
complex, CPSF, a protein bound to RNA polymerase II, binds to the RNA and pauses tran-
scription. G/U rich sequence that follows is then bound by CtsF and promotes the cleavage
of the RNA by CPSF between these two signals. The resulting upstream RNA molecule is
polyadenylated and completes its maturation while the downstream product is degraded by
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XRN2. It is thought that when XRN2 encounters RNA polymerase II when it is degrading the
RNA that it promotes the release of RNA polymerase II from the DNA and helps the final stage
of termination.35 Interestingly, the genes for histone proteins do not use a Poly(A)-dependent
mechanism for termination but rely on a stem-loop mechanism instead.36 Cleavage of the
stem-loop-dependent termination is similar to that of Poly(A)-dependent termination in that is
occurs between two elements, the stem-loop and a purine-rich histone-downstream element,
and it is cleaved by CPSF36. The stem-loop is a pair of sections of RNA with a short linker
between them. The two sections of DNA bind to each other to form the stem, leaving the
linking section as a loop. The current knowledge of transcription termination is a rapidly de-
veloping field, so much so that four reviews have been published in the last three years; each
addressing the new knowledge that has been accumulated.37–40
Enhancers and Repressors
Transcription as described so far is the general case and results in a low basal level of tran-
scription. The genes need to be enhanced to increase transcription beyond this background
level. To reduce or stop transcription, genes need to be repressed. Specific transcription fac-
tors, as opposed to the general transcription factors so far described, are responsible for each
of these roles and this is how cells exert control over the specific genes that are transcribed to
determine cell fate, function and respond to extra- and intra-cellular signals.
Enhancer regions are sections of DNA, normally about 100 bases long, which are bound by
transcription factors that promote transcription. They contain several short 6-12 base transcrip-
tion factor binding motifs. These motifs have some degree of conservation that the transcription
factors can recognise. There are many different mechanisms by which enhancers and their
associated transcription factors function. Co-operative binding occurs where transcription fac-
tors associate with each other to enhance transcription. An example of this is the recruitment
of p300 to the enhancer of INFβ . p300 associates with NFκB, IRF1 and c-Jun.41 Individually
they do have an effect on transcription but together the effect is amplified. This often occurs
where the transcription factor interacts with the transcription initiation complex. Co-operative
enhancers can occur at a single site; two transcription factors can, counter intuitively, pro-
mote transcription despite competitively binding to the same binding site. It is thought that
this occurs as the transition between the two transcription factors leaves less opportunity for
nucleosomes to re-associate with the open DNA.42
The binding of a transcription factor can cause local bending in the DNA. The change in
the conformation of the DNA can open up enhancers to transcription factor binding or open
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promoters to the initiation of the transcription initiation complex. The bending of DNA can also
bring transcription factors into the proximity of the transcription initiation complex, enhancing
its propensity to undergo promoter clearance.43;44
Transcription factors are compete for binding sites on the DNA with nucleosomes. Binding
by transcription factors such as Pu145 and CEBPβ 46 to their enhancers leads to remodelling
of chromatin and the opening of the local DNA to the binding of other transcription factors.
This is the first stage in the differentiation of the cells to several different possible cell-types.
The effect that transcription factor binding has on nucleosomes is complicated. The binding
of transcription factors is dependent on the chromatin state but the chromatin state is also be
dependent on the transcription factors that are bound.
The organisation of the motifs also has an important effect on the function of the enhancers
and their associated transcription factors. The order of the enhancers on the genome deter-
mines which transcription factors interact; changing the order of the motifs moves the interface
between two proteins so that they are no longer able to interact. Changing the direction of
the motif can have the same affect as it changes the orientation in which the transcription
factor binds.47;48 If the distance between two motifs changes, the location of the two transcrip-
tions factors around the DNA helix will be changes, also disrupting the interaction of the two
proteins. No general pattern has been found between the order, orientation or separation of
transcription factor binding motifs.49
Repression of transcription shares many similarities with the enhancement of transcription.
Many of the mechanisms, such as co-activation, are the same for repression but instead of the
bound transcription factor promoting the binding of the pre-initiation complex, or the progress
from initiation to elongation, it reduces or completely inhibits them.50 Repression is used as a
fine-grained control over the levels of transcription. Oct4 is an essential transcription factors
that not only maintains pluripotency in embryonic stem cells but also determines cell fate. Dif-
ferent levels of Oct4 determine whether a cell continues as a stem cell or begins differentiation,
and what it will differentiate to.51;52 Oct4 expression is complicated and not fully understood.
Cdx2 has been shown to repress the transcription of Oct4, but it requires the presence of other
factors such as Brg1.53 Repression is as tightly controlled as enhancement of transcription
and often requires multiple-levels of transcription factor binding. Repression also allows cells
to maintain proteins in a poised state. This poised state means that the transcription initiation
complex is bound but never progressed to the elongation phase. This allows a rapid response
to signalling and allows the cell to very quickly start transcription of the poised gene.50;54;55
This is a simplified overview of enhancement and repression of transcription. It has been
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known for a long time that the function of a transcription factor is not always clear and that
they can both repress and enhance the transcription of genes depending on the surrounding
environment.56–58 Establishing the function of transcriptional enhancers and repressors is diffi-
cult. Transcription enhancer regions are often located remote to the promoter and transcription
start site. Since DNA functions in a three-dimensional environment these can be a large dis-
tance between the enhancer and the gene it enhances. The multiple layers of interactions
also makes it harder to understand a single transcription factors effect. The vast networks of
interactions lead to different results dependent on which other proteins are present. It has
only been recently, with the development of new sequencing technologies, that is has been
possible to get a whole-genome over-view of the location of individual transcription factors on
the genome and the investigation of these complicated processes.
Predicting Transcription Factor Binding Sites
Much work has been done on the prediction transcription factor binding motifs; the short set of
nucleotides that each transcription factor binds to. Transcription factors are specific in the mo-
tifs which they bind to; incorrect binding could have disastrous consequences for the cell. This
is advantageous for the prediction of the transcription factor binding motifs as it means they
are often highly conserved. There are publicly available databases, such as JASPAR,59 and
TRANSFAC60 that contain experimentally determined binding motifs for transcription factors.
The motifs generally consist of a position weight matrix with the probability of the occurrence of
each base at each location in the motif. These matrices can then be combined with methods,
such as MOODS, to identify potential transcription factor binding sites.61 MOODS searches
through the DNA sequence for the most likely sub-string, determined from the position weight
matrix, to identify potential binding sites. After these core sections have been identified, they
are assigned a p-value based on the whole of the position weight matrix.61
Despite the work that has been done in predicting transcription factor binding sites using
motifs it is still a difficult and largely unsolved problem. The methods produced, though capable
of providing predictions of whether a motif is present or not, are not always reliable. Due to
the small size of the motifs (∼6bp) and each base being only 1 of 4 nucleotides there is a high
probability that the motifs can occur by chance. A 6-base motif would be expected to be seen,
by chance, once in 4096 bases. With a genome as large as that of humans, approximately
3 billion bases, naively assuming a random distribution of bases, there would be, by chance,
over 700,000 occurrences of each 6-base motif. The short length of the motifs mean that there
they do occur by chance in the human genome. This is problematic for predicting transcription
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factor binding sites just using position-weight matrices; the methods currently available lack the
context that occur in the cell to determine whether, at that specific location in the genome, the
sequence is a valid binding site. There are numerous other problems, beyond the statistics,
that make predicting binding sites problematic. The poorly understood biology behind the
binding of many transcription factors, variability in the affinity of binding and the variability
in the sequence a protein will bind to all add to the complexity of the problem. Even more
complexity is added when the variation of each base in the binding motif is not assumed to be
independent of every other base, as is the assumption when using position weight matrices. It
has been show that often the variation in the bases is dependent on the variation in the other
bases of the motif.62 Position weight matrices are still commonly used however, due to their
relative simplicity.
1.1.4 Gene Ontology
The Gene Ontology (GO) is a collaborative project which aims to provide a consistent descrip-
tion of gene function across a number of different organisms. It contains 3 sub-ontologies
that describe the associations of the gene product: Cellular Component, Molecular Function,
and Biological Process. The Cellular Component ontology describes the locations of the gene
product in the cell or extracellular matrix where it is often found (e.g. the cytoplasm or inner
membrane). The Biological Process ontology describes the molecular events or process with
which the gene product is associated. The Molecular Function ontology describes the molecu-
lar activities of the gene product. The terms are designed to be simple, concise and descriptive
in order to minimise the amount of time and effort needed to identify the function, location and
actions of a gene product.
1.2 Sequencing the Genome
The increase in the rate at which it is possible to sequence DNA is increasing every year .
What originally took the human genome project years to complete is now possible in days,
potentially hours. The rapid increase in the speed of sequencing also brings with it a massive
wealth of data. Studies using vast ranges of binding data from transcription factors and histone
modifications are now possible. As the sequencing technologies become quicker, cheaper,
and easier, the function and interplay between all of the regulatory units of transcription and
cellular function are going to become clearer.
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1.2.1 Sanger Sequencing
Developed in 1975 by Frederick Sanger,63 Chain-termination, or Sanger Sequencing, was
one of the main methods for sequencing DNA, prior to the newest generation of sequencing
methods. Sanger sequencing uses modified nucleotides, dideoxynucleotides, to terminate the
extension of DNA replication. Single-stranded DNA is separated into four separate reactions.
Each reaction has a full range of normal deoxynuceleotide, a DNA polymerase, and a single
type of dideoxynucleotide. The DNA is allowed to extend; where the dideoxynucleotide is used
the extension is terminated. This results in chains of different lengths. All four reactions are
then heat denatured and run through gel electrophoresis. These different lengths from the
reactions containing each dideoxynucleotide can then be read off the gel, giving the sequence
of the DNA. This method can sequence DNA strands of up to 1000 bases but it is expensive
and time-consuming.
1.2.2 Current Generation Sequencing
The current generation of DNA sequencing has a massive advantage over Sanger sequencing
as it is massively parallel. Sanger sequencing only samples a single section of DNA at a time.
The new sequencing methods can sequence millions of reads for each run of the machine.
Being able to sequence millions of reads during a single run of the machines means that it
is possible to sequence across the whole of a genome, or a smaller sequence of DNA a vast
number of times, where previously it would have been only possible to sequence a single,
relatively short, section of DNA. Three of the main sequencing methods, developed by three
different companies, are 454 Sequencing, Illumina Sequencing and SOLiD Sequencing.
454 Sequencing, like Sanger sequencing, relies on “sequencing by synthesis”, whereby
the complementary strand to the target must be made, step by step, and the nucleotide is then
detected to determine the sequence. This is done using parallelised pyrosequencing. DNA
is immobilised into beads in wells on a plate to act as the template. Nucleosides, specifically
deoxynucleoside triphosphate, are added to the wells and flushed off, one at a time. If the
current nucleotide is incorporated into the DNA strand, the release of pyrophosphate causes
fluorescence which can then be detected; the order of the bases in the template sequence can
then be deduced. 454 Sequencing produces reads of about 300-500 bases.64
Illumina Sequencing also relies on the synthesis of the complementary strand of DNA to
the target strand, but all of the nucleotides needed for the synthesis are included in a single
stage. The DNA molecules that have been enriched by ChIP are attached to a slide. The at-
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tached DNA is then clonally amplified; multiple copies are created in a small region to make the
imaging stage of the process easier. The nucleotides used in this process are reversibly bound
to a dye-terminator which fluoresces when bound. Each base fluoresces a different color and
inhibits further extension of the DNA chain until the dye-terminator is removed. Illumina Se-
quencing involves repeated steps to extend the complementary DNA by a base, flushing away
of the unused nucleotides, recording the fluorescence, and removing of the dye-terminator
from the base. Illumina Sequencing is very fast and produces read lengths of up to 200 bases.
The recently released Illumina machines can produce reads up to 500 bases in length, though
the accuracy is severely reduced at the far end of the reads.65
The third method, SOLiD (Sequencing by Oligonucleotide Ligation and Detection) sequenc-
ing, is based on the principle of “sequencing by ligation”. Instead of adding a single base and
recording which base is added, all possible combinations of 8-base sequences are present and
uniquely marked in the reaction mix. These oligonucleotides have a cleavage site between the
5th and 6th base. SOLiD sequencing comprises of 5 rounds, each round having 5-7 cycles.
Firstly, a universal primer is bound to the DNA, then the reaction mixture containing the 8-base
oligonucleotides is added and the oligonucleotides allowed to bind to the DNA. The reaction
mix is then washed off and the fluorescence of the bound oligonucleotides is measured. The
oligonucleotide that has bound is then cleaved, removing bases 6, 7 and 8, as well as the fluo-
rescent signal. The process then continues with the addition of the reaction mix. This process
is repeated several times, extending the chain and recording the oligonucleotide sequences
that have bound. For the next round, a universal primer binds so that it ends one base before
the previous primer ended. This means that each time an oligonucleotide binds, the cleaved
bases are tested and, due to the shifting of the primer, each base gets tested twice. The read
lengths produced by this method are about 200 bases in length.66
1.2.3 Chromatin Immunoprecipitation
Chromatin Immunoprecipitation, or ChIP, is a process for selectively enriching short segments
of DNA which are bound by target proteins or epigenetic markers, such as a modified histone
protein. First, all the proteins bound to the protein are covalently bound to the DNA, normally
using formaldehyde. The DNA is then sonicated to break it into small segments. The segments
of covalently bonded DNA are then selected for by the addition of beads with the appropriate
antibody for the protein bound to them. The beads are then isolated and the final step is
completed, breaking the covalent protein-DNA bonds and leaving the isolated DNA67.
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Chromatin Immunoprecipitation and the new sequencing methods are now often combined
to form a powerful method for identifying the location of transcription factors or histone mod-
ifications across the genome. As ChIP enriches DNA sequences that a target factor bound
to, subsequence sequencing of these DNA sequences allows alignment of the resulting se-
quence to a reference genome. Aligning the sequences to the genomes allows the binding
sites of transcription factors or presence of histone modifications to be studied on a genome-
wide scale.
1.2.4 DNase-seq
DNase-seq has been used to identify open chromatin across the genome. DNA is cleaved
using DNase I. Biotinylated linker I is added to the cut-ends of the DNA. The DNA is then
selected and amplified using PCR, followed by high-throughput sequencing normally using
the Illumina methodology.68 DNase-seq is a genome-wide method which allows scientists to
analyse how accessible the DNA is to transcription factors and the transcription factor binding
machinery; if the DNA is not accessible, then it can not be transcribed.
1.2.5 Alignment and peak calling
Alignment
Next generation sequencing produces many short reads, spread across the genome where
target proteins have been bound or histone markers found. The next stage is locating where
these reads actually belong on the genome. Where a reference genome sequence is available,
it is possible to align the DNA sequences from the sequencing to the same sequence from the
reference genome. Two of the most used programs, BWA69 and BowTie70 use the Burrows-
Wheeler Transform for the alignment. Ideally, a read will only align to a single location along
the genome. Issues arise where a read will map to multiple positions in the genome. Where
the read can align to multiple places on the reference genome they are given mapping scores.
Mapping scores are used in later stages of analysis where reads with a mapping score below
a set threshold are discarded.
Peak Calling
Peak calling is a common method for identifying transcription factors and for histone modifica-
tion sites from ChIP-seq data. The general aim of peak calling is to identify where reads are
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significantly enriched compared to the background, and hence to identify where the target tran-
scription factor or histone modification is bound. Generally, to normalise the ChIP-seq data,
the data is either compared to a control run of data generated using non-specific antibodies (or
the input DNA which has not undergone ChIP) or to multiple other Chip-seq datasets. A simple
method used to normalise the data is to scale the total number of reads for each dataset up
to the same number as the largest dataset. This is done by calculating a scaling factor (the
largest number of reads divided by the number of reads for the current dataset). This is a
broad, linear scaling factor that will allow a fair comparison of the number of reads at any point
in the dataset. The simplicity of this method poses some problems. The scaling amplifies the
valid peaks, but also artificially inflates any erroneous peaks, as well as any background noise.
It assumes that there is a uniform distribution of background reads across the dataset, as well
as a similar distribution of reads across both of the datasets being normalised. A problem with
peak calling algorithms is that they are often only optimised for the detection of sharper tran-
scription factor binding peaks, the broader peaks of histone modifications or RNA polymerase
II binding. As transcription factors bind at specific promoter/binding regions that are very small
and precise, the manner in which the reads line up over this area cause tall, thin peaks. Hi-
stone modifications and RNA polymerase II and act over a much larger length of DNA which
causes broader, lower peaks, compared to the peaks cause by transcription factors.
MACS71 is a highly-used open-source peak finding tool. The first step MACS takes in
the process of calling peaks is to estimate the split between the peaks for each binding site.
Since DNA is double-stranded, and each strand has an equal chance of being selected and
sequenced, a bi-modal peak occurs where the transcription factor of interest binds. MACS
calculates the shift-size between the two peaks using a sliding window twice the size of the
sonication-fragment; it looks across the genome for these bimodal peaks. MACS then models
the reads across the genome using a Poisson distribution. All of the reads are moved by half
the calculated shift-size in the 3’ direction of the tag to align the bimodal peaks, then slides
a windows twice the shift-size along the genome to detect these merged peaks. A dynamic
expected number of reads, λlocal , is used to calculate the probability of the number of reads in
the peak due to chance and any peak with a p-value below 10−5 is highlighted as a binding
site. λlocal is calculated as in equation 1.1.
λlocal = max(λBG ,λ5k ,λ10k) (1.1)
15
where λ5k and λ10k are the number of events per interval of a 5 kb and 10kb window
centered on the peak, respectively. λBG is the number of events per interval for the whole
genome or the control dataset if available. This dynamic calculation of λlocal allows for a robust
calculation of the p-value for each peak which accounts for local variation in the background
noise.71
Another peak calling algorithm, PeakSeq72, uses three stages in the identification of peaks.
Firstly, a signal density map is produced from the uniquely aligned reads on the ChIP-seq data.
This involves extending the reads in the 3’ direction to the length of the DNA fragments in the
sequencing library (normally about 200bp). Once this has been done the signal density map
can be generated as the number of reads that overlap each base. In the next step, PeakSeq
identifies all of the regions in the sequence density map that are significantly higher when
compared to a simulated null background model, in 1Mb segments across the genome. The
peaks that are identified as potentially significant are then compared to the control dataset.
10kb windows across the control and sample data are used for linear regression, with the
counts for the control data then being scaled by the slope of the regression line to normalise the
two datasets. Any potentially-significant peaks are then compared to the normalised control
data and any peaks which are significantly enriched compared to the control are highlighted
as binding sites. p-values for the peaks are calculated using a binomial distribution.72
PeakRanger73 builds on PeakSeq with the aim of being able to detect the sharper peaks of
transcription factor binding and the broader peaks of histone modifications or RNA polymerase
II binding. PeakRanger uses the same methods as PeakSeq to identify potential peaks then
uses a “summit-valley-alternator” algorithm to identify the highest point in each peak above a
certain threshold, calculated by multiplying the height of the current highest point by a user-
defined constant. This is effectively looking for peaks followed by troughs, requiring the height
of the reads to fall below the threshold before another peak can be called. This method can
look for both steep peaks with small bases, and lower, broad peaks, and can also distinguish
between peaks that are close together.73
1.2.6 Previous Computational Approaches
With the development of high-throughput sequencing data comes a wealth of new data. There
have been very few computational studies looking at using either transcription-factor data or
histone-modification data to predict expression.
Studies have been done into using transcription factors to predict gene expression. Ouyang,
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Zhou and Wong took the approach of using principle component analysis to construct models
using 12 transcription factors from mouse embryonic stem cells. Ouyang et al. developed a
metric that uses peak intensity and the proximity of the ChIP-seq peak to each gene. The
influence a transcription factor has on a gene is the weighted sum of the intensities of all of
the transcription factors peaks, termed the transcription factor association score. The weight is
based on the proximity of the ChIP-Seq peak to the gene and tends to 0 for the peaks further
than about 10kb. The decay in the weight for a peak decreases exponentially the further from
the gene it is located, meaning that the largest contribution to the association score is from
the ChIP-seq peaks closest to the gene. This is calculated for each transcription factor with
each gene. They compared using a binary classifier, stating simply whether the transcription
factors is bound to the gene or not, and continuous version of their metric and found that using
a continuous metric resulted in far better models than using a binary metric.74 Principle Com-
ponent Analysis is a regression method that converts a set of data into uncorrelated subsets
of the data. Each of these subsets is comprised of a weighted sum of the original datasets that
explains a part of the total variation of the observed data. Principle component analysis was
used as it allows different combinations of transcription factors to have positive and negative
effects on a genes expression depending on what other transcription factors are bound, with
each of the different combinations being contained in a separate principle component. While
this is good in principle, the first principle component found contained only one transcription
factor and accounted for almost half of the variance in the RNA-seq data used as a measure
of transcription. Ouyang et al did, however, find that their first three principle components
accounted for almost 70% of the variance in the RNA-seq data and was able to identify dif-
ferentially expressed genes in the embryonic stem cells.74 The transcription factor association
score Ouyang et al developed starts approaching the problem of distal transcription binding
sites; sites that are not necessarily close to the gene but has influence on its transcription. It
does not, however, fully encompass the problem as there is still no accounting for long-range
distal effects or 3-dimensional folds in the DNA. The approach uses a simplistic idea that the
further from the gene a binding site is, the less likely it is to influence the genes expression.
While this is a safe general assumption it is quite possible that the cases where this assump-
tion is incorrect, such as enhancer regions that have a strong influence on gene expression,
will have a significant effect on the model.
Cheng and Gerstein used support vector regression to investigate the relationship between
transcription factor binding, histone-modification presence and expression.75 Using ChIP-seq
data from 12 transcription factors and 7 histone modifications from mouse embryonic stem
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cells they constructed models using support vector regression to investigate how transcription
factors and histone modifications interact to predict RNA-seq expression data and the redun-
dancy within and between the transcription factor and histone modification datasets. The level
of marker binding was established by taking an area +/- 4kb from the transcription start and
end sites of refSeq genes and splitting these regions into 100bp bins, resulting in a total of
160bins for each gene. The coverage of each nucleotide for the transcription factor or histone
modification was averaged over the 100bp section and this value was used as the signal for
that bin. A signal profile was the calculated as the average signal for the transcription factor
or histone modification for each of the bins over all the genes. These signal profiles were then
normalised to a total value of 1 to make profiles for the different datasets comparable. Support
vector regression was used to predict expression levels for each gene from the transcription
factor and histone modification binding signals. The support vector regression was trained and
tested multiple times of different testing and training subsets of the data and the average of the
resulting Pearson correlation coefficients were used as the correlation between the support
vector regression-predicted expression levels and the expression data from RNA-seq or mi-
croarray experiments. Unsurprisingly it was found that transcription factor binding is predictive
of expression levels. It was also found, using principle component analysis of the bins for the
transcription factors, that the influence of the transcription factors extends only as far as 2kb
from the transcription start or end sites. Past this range, the contribution to expression of the
transcription factor was minimal. Histone modifications were also found to be predictive of tran-
scription, though marginally less so than for the transcription factors. The histone-modification
data was found to contribute to expression across the whole of the region investigate though,
in contrast to the decreasing contribution at range of the transcription factors. Most interest-
ingly in this study, it was found that transcription factors alone, histone modifications alone or
histone modifications and transcription factors combined were roughly equivalent for predicting
expression, and the authors go on to highlight the statistical redundancy between the histone
modification and transcription factor data.75 A potential problem with this method of generating
the binding signals for the datasets the focus is has on the transcription start and end sites.
Histone modifications have different profiles across the gene; some having peaks at the tran-
scription start site that tails off through the gene, while others are more often found as broad
peaks that span the majority of the gene-body. Using just an 8000 base region that is centered
on the transcription start and end sites is likely to miss the nuances of histone modification
presence, especially in cases where the majority of the binding is found in the gene-body.
More recently, Cheng et al. have applied the method they previously developed, as de-
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scribed above, to a much larger set of data from the ENCODE project.76 They apply this previ-
ous established method to a set of over 400 binding profiles for over 120 transcription factors
and histone modifications in “many different cell lines”.76 They use a set of 267 expression pro-
files for RNA samples from 12 different cell lines. Investigations on this scale are now only just
becoming possible with the release of the ENCODE data. The Random Forest machine learn-
ing algorithm was used in this investigation for models with multiple predictors, while Support
Vector Regression was still used for models with a single predictor. Their aim was to investi-
gate the difference in transcription factor signals at transcription start sites and the contribution
of different types of transcription factors to expression. With this vast amount of data from
many cell lines, they were also able to show that differential binding of transcription factors is
able to explain the differential expression of genes. When investigating the effect of different
types of transcription factor, it was found that the presence of non-specific transcription factors
was the most predictive of expression, followed by sequence-specific transcription factors and
Chromatin restructuring proteins. This is an unsurprising result, as the general transcription
factors are so essential for the association of the transcriptional machinery, but goes some way
to validate that the method they are using is biologically relevant. The redundancy between the
histone modification and transcription factor data was again show here by the comparison of
models using the histone modification data, transcription factor data and a combination of the
two. A 8% difference in the amount of variance explained when the histone modification data
was added to the transcription factor model and a 13% difference in the amount of variance
explained was found when the transcription factor data was added to the histone modification
model. This shows that while the two difference sets of data are largely statistically redundant,
there extra information contained in each that the other lacks.
1.2.7 Importance of understanding genetic regulation
The understanding of genetic regulation is vital for the full understanding of stem cells, cell
fate, cancer, many diseases and how cells function. The advances in sequencing technolo-
gies have opened up a vast range of new potential studies with the genome-wide identification
of transcription factor binding and histone modification presence. Being able to measure vari-
ables across the whole genomes means that the subtle interplay between transcription fac-
tors, histone modifications and DNA accessibility can now be investigated. The huge volume
of data being produced by the new sequencing technologies is complicated. New analytical
techniques are being developed to address the issues associated with the volume of data and
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the noise that it potentially contains. New statistical methods are also being developed to help
understand what the data shows as well as to combine and integrate the wide range of data
together.
Investigations into the way in which transcription is regulated, what transcription factors
and histone modifications are found in transcribed regions, and the vast and complex network
of control that the cell exerts over transcription are now underway. By understanding fully the
mechanism that controls transcription the potential for stem cells in treating disease can be
unlocked and new, potentially individual-specific, treatments for cancer can be developed.
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Chapter 2
Genetic Regulation in Mouse
Macrophage Cells
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2.1 Introduction
Macrophage Activation and Function
Macrophage cells are generally classified as either classically-activated/M1 macrophages or
alternatively-activated/M2 macrophages. More recently macrophages have been described
as having three types, with a continuous variation between the types, rather than there being
strict differences between the types.77 Macrophages have three main roles: immune defence,
removing damaged tissue and regulating inflammation. Whilst their functions are well defined,
macrophages are difficult to classify as all types of macrophage can transition between each
of these functions.
Classically-activated macrophages are produced during cell-mediated immune response
and also produced in the short-term by stress. They comprise about 90% of the macrophage
population in humans.78 These macrophages are responsible for phagocytosing (engulfing
and destroying) bacteria and cell fragments from apoptosis. Classically-activated macrophages
are recruited from monocytes circulating in the blood under stimulus from injury, infection
or antigen-specific immune cells. Interferon-γ (INFγ) and Tissue Necrosis Factor (TNF) are
needed to induce classically-activated Macrophages.79;80 In the innate immune response,
INFγ is produced by natural killer cells as a response to infection or stress. This is only a
short-term effect though and the macrophage population is not maintained.81 T-Helper 1 cells
from an adaptive immune response prime macrophage cells to secrete pro-inflammatory cy-
tokines and superoxide anions to help defend against the threat and to increase the pathogen-
killing power of the macrophages. To maintain a population of macrophages, signals from an
adaptive immune response are needed, such as the antigen-specific response of T-H 1 helper
cell and antigen presenting cells. Although there are alternative signals that can replace INFγ
and TNF, these two signals together are generally accepted to be the initiators of classically-
activated macrophages.77
Alternatively-activated macrophages can be split roughly into two populations, the functions
of which can overlap. Regulatory-macrophages arise at the end of a period of inflammation;
their role is to limit inflammation and reduce the immune response as it is no longer required.82
Unlike classically-activated macrophages, there doesn’t appear to be a single molecule, or pair
of molecules, that is responsible for the development of alternatively-activated macrophages,
though extracellular-signal-related kinase has been strongly implicated as a mediator.83 Reg-
ulatory macrophages need multiple signals to induce their development, although they do not
have a primary pair of molecules.84 Regulatory macrophages release IL-10, a cytokine with
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immunosupressive properties.85 Wound-healing macrophages, able to be induced by treat-
ment of monocytes with IL-4, are similar to regulatory macrophages but also possess the abil-
ity to secrete components of the extracellular matrix.84 The main purposes of wound-healing
macrophages are to to clear up loose, and potentially disruptive cell fragments from the site
of a wound, secrete parts of the extracellular matrix and be ready to respond to infection. The
function of a macrophage, once differentiated, is not static but can be altered depending on
the signals received. This plasticity is an important part of the immune response, allowing the
body to react to changes in conditions during infection or would-healing.84
2.1.1 Important Transcription Factors
Pu1 (or Spi1) is a cell-fate-determining transcription factor; active genes in macrophage cells
are almost always bound by Pu1, especially those with the H3K4Me1 histone modification.45;86
It is thought that the binding of Pu1 recruits chromatin remodelling factors to change histone
modifications on nucleosomes surrounding the binding site.87 The recruitment of these chro-
matin remodelling factors opens up the DNA, allowing other factors to bind that would other-
wise be unable to bind when the binding sites are within a nucleosome.88 Although Pu1 is
involved in promoting transcriptional activity, its main function is to open up sections of the
DNA to allow other transcription factors to bind. Having a single transcription factor act as
the enhancer for the majority of genes allows lineage-dependent control of which genes are
able to be activated.89 While Pu1 binding allows regions of the genome to become activated,
it does not automatically mean that the transcription apparatus is recruited to the genes or that
the cell needs the genes transcribed. Two important transcription factors that control whether
a gene in these enhancer regions is active or not are the p65 sub-unit of NFκB (henceforth
referred to as p65) and B-Cell Lymphoma protein 6 (Bcl6).
Bcl6, despite being primarily known for the involvement it has in B-Cell differentiation
and lymphomas,90 is found in many cell types and is essential for regulating expression in
macrophages.91 It has been found to maintain a low background level of transcription of genes
that are induced by cellular exposure to lipopolysaccharides (LPS) but also limits the maxi-
mum rate at which these genes can be transcribed.92 Exposure of macrophages to LPS has
been shown to cause a dramatic (>90%) drop in the binding of Bcl6 to its target genes.93 The
majority of Bcl6 binding occurs at distal sites, often occurring in Pu1 activated regions.94
p65 is a well known and studied inflammatory transcription factor which is only able to
bind where the DNA is not in a nucleosome.88 When a cell encounters a signal from Toll-Like
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Receptors (TLR) or Tissue Necrosis Factor Receptors (TNFR), p65 is able to bind to its target
genes; these are normally inflammatory genes and are often located within Pu1 enhancer
regions.94 The activation of genes by p65 often involves direct or indirect expellation of pre-
bound repressors, such as Bcl6, from their binding sites.92;95
CCAAT/enhancer-binding protein (CEBP) α and β are members of the bZip family of tran-
scription factors. CEBPα is well-known essential transcription factor for the differentiation
of monocytes to macrophage cells when activated by CSF1R.96 CEBPα binds to the pro-
moter and distal enhancer of Pu1,97;98 its own promoter,99 and genes essential for expres-
sion of macrophage specific genes and chromatin remodelling.100 CEBPα initiates the start
of differentiation through the expression of Pu1, as well as by forming a feed-forward loop
with itself, committing to the act of differentiating. When expressed above a basal level it
also inhibits proliferation in cells.101 Due to this anti-proliferation ability, mutations in CEBPα
lead to acute myeloid leukemia (AML)-like transformation in the cells (an early stage in the
development of AML).101 When CEBPα is activated by cAMP-responsive element-binding
protein (CREB) it regulates alternatively-activated macrophage-associated genes.102 Induc-
tion of CEBPβ by CREB is only required for genes associated with alternatively-activated
macrophages; CEBPβ is involved in the activation of classically-activated macrophages though
it is thought that its expression is activated by a different mechanism than CREB binding.103
Macrophage activation is essential for the production of an inflammatory response to lipopolysac-
charides (LPS) molecules present on the surface of gram negative bacteria. Both CEBPα and
CEBPβ can, when a macrophage encounters LPS, activate cytokine production to defend
against the offending bacterial cell. Experiments have shown that cells lacking CEBPβ or
CEBPα are still able to produce these cytokines, though cells with only CEBPα had a lower
response to the LPS stimulation than those cells with only CEBPβ.103 This shows that CEBPα
can compensate for the loss of CEBPβ in some circumstances,103 as it has also been shown
that CEBPβ can compensate for the less of CEBPα,104 though in both cases the effect is less
than optimal. Overall, despite their perceived functional redundancy, CEBPα is more involved
in the differentiation and maintenance of macrophages while CEBPβ is more involved in im-
mune responses and cytokine production, although they assist one another in fulfilling these
roles.
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2.1.2 Aims & Objectives
The aims for this chapter are to investigate the relationship between the histone markers
(H3K4Me3 and H3K4Me1), transcription factors (Pu1, p65, BCL6, CEBPα and CEBPβ), RNA
polymerase II binding, and DNase I hypersensitivity. The objective is to create a simple model
that will use the transcription factors, histone modifications and DNase I hypersensitivity to
predict the level of RNA polymerase II binding. RNA polymerase II binding is used here as a
metric for the level of transcription. The level of RNA polymerase II binding is generally indica-
tive of the level of protein production; RNA Polymerase II binding has been shown to correlate
with expression data.74;105 A simple model for RNA polymerase II binding will help lead to a
mechanistic hypothesis for the activation of genes. By investigating which of these factors is
the most predictive, and how the different factors interact in the models, it will be possible to
investigate further into the control of transcription.
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2.2 Methods
2.2.1 Data sets
The data used were all from bone marrow derived-mouse macrophage cells, grown in the
same conditions. All of the datasets were for unstressed cell (i.e. not treated with lipopolysac-
charides). Due to the differences in macrophages throughout the body only macrophages from
one tissue-source of macrophages were used. Three experiment sets were used, accessed
using the NCBI GEO database106 or provided by the Bonifer Lab. The datasets used are
detailed in table 2.1.
Epigenetic Marker GEO Accession Reference
RNA Polymerase II - Unpublished Data
H3K4Me3 - Unpublished Data
CEBP α - Unpublished Data
CEBP β - Unpublished Data
DNase I Hypersensitivity GSE26550 Leddin et al. 107
BCL6 GSE16723 Barish et al. 92
p65 GSE16723 Barish et al. 92
IgG GSE16723 Barish et al. 92
H3K4Me3 GSE21512 Heinz et al. 86
Pu1 GSE21512 Heinz et al. 86
Table 2.1: The datasets used for the epigenetic analysis of mouse macrophage cells
2.2.2 Enrichment Calculations
Read counts were used instead of using complicated peak-finding algorithms and the normal-
isation calculations. There is currently no normalisation calculation available which does not
have some significant problem.108;109 Instead of using the peak-finding algorithms, a much
simpler enrichment calculation was used. The enrichment calculations are normalised within
the dataset using a background noise factor directly from the data. This means that the result-
ing values are comparable between datasets as well as within datasets and removes the need
for normalisation between the datasets, which inevitably involves the loss of information. The
conservative nature of the background factor should also reduce the number of false positive
results. Three different enrichment values were calculated for every gene in each dataset.
Firstly, an enrichment value was calculated for the region between the transcription start and
end sites (the Gene Enrichment) as defined by the NCBI refSeq entries for the gene.110 Sec-
ondly an enrichment value was calculated for two 2000 base sections, one that spans 2000
bases upstream of the transcription start site and one that starts at the transcription end site
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and extends 2000 bases downstream (the Flanking Enrichment). Lastly, an enrichment value
was calculated for a region starting 2000 bases upstream of the transcription start site and
terminating 2000 bases beyond the transcription end site, thus encompassing the flanking re-
gion and the gene in a single enrichment calculation (figure 2.1). 2000 base flanking regions
were used as a definition of the flanking as this is the region where it is most likely that the
transcription factors will bind.111
Figure 2.1: The three regions used for the enrichment calculation. Firstly the number of reads
were calculated for the gene, secondly for two 2000 base flanking regions either side of the
gene and thirdly for a region that spans the gene and both flanking regions.
E =
RRegion
BG × l (2.1)
The enrichment, E, is calculated by dividing the number of reads in the current region, RRegion,
by the largest average background reads per base, BG (described below), multiplied by the
length of the current region, l (equation 2.1).
Background Calculation
BG =
max(RGenome ,RChromosome ,RLocal)
Bases
(2.2)
The background average, BG , is the biggest average number of reads per base from a se-
lection of potential background areas divided by the number of bases for the current gene
(Bases, equation 2.2). The areas used for the calculation of the background were the whole
of the genome (RGenome), the chromosome on which the gene is located (RChromosome) and a
more local region comprising the two 10kbp regions directly surrounding the gene/flanking
region (RLocal ). This background metric was motivated by use of a similar background term
in the MACS algorithm for identifying local bias.71 MACS uses the maximum of a Poisson-
distribution-based background, a 2000bp, or a 5000bp window centered on a peak to deter-
mine a p-value to filter out false-positive peaks.
2.2.3 Linear Models
Linear models were created using the RNA polymerase II enrichment data as the observa-
tion/response variable and the other factors (CEBPα, CEBPβ, DNase I hypersensitivity, BCL6,
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p65, IgG, H3K4Me3, H3K4Me1, Pu1) as predictors. The purpose of the linear models was
to fit and optimise the combination of the predictors to the RNA polymerase II data. With this
platform is is possible to then re-run the models with predictors removed and observe the im-
provement or degradation in the combination of predictors ability to model RNA polymerase
II binding. Both forward and backward stepwise elimination methods were used to build the
linear models and both methods resulted in the same optimal regression model in each case.
yi = β0 + β1xi1 + β2xi2 ...βpxip, i = 1, ... , n, (2.3)
Equation 2.3 is the general equation for a linear model, where yi is the response variable for
gene i , x are the regressors (in this case, the enrichment values for the datasets), β0 is the
intercept term and β are the regression coefficients. Linear models were generated using the
“lm” function of the R statistical computing package.112 The log of the enrichment was used for
the linear models for better scaling and to ensure a linear relationship. Any enrichment values
for which the RNA polymerase enrichment was 0 were removed before the log was taken. Any
enrichments of the predictors which had a value of 0 were increased by 0.0001 to allow them
to be logged but to have a minimal effect on their value relative to the rest of the data points.
The resulting models were assessed based on their coefficient of determination (R2) and
Bayesian Information Criterion (BIC) score as described in equation 2.4.
−2 · ln p(x |k) ≈ BIC = −2 · ln L + k ln(n) (2.4)
Where x is the observed data, n is the number of data points, k the number of regressors,
p(x |k) the probability of the observed data given the number of regressors and L the maximised
likelihood function of the model. The BIC value of the model gives an indication of how efficient
the model is accounting for the complexity of the model relative to the number of regressors that
are used. When comparing two regression models, the one with the lower BIC is preferable.
2.2.4 Outlier and Inlier analysis
The genes which the linear model predicted the enrichment values for RNA polymerase II
well and poorly were investigated further. The aim of this was to try and establish whether
there were any type or function of genes, such as response effector or differentiation genes,
for which these simple models, using only a few important transcription factors and histone
modifications, were predicted particularly well or poorly.
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For the optimal model and the transcription factor-containing mode for the gene and flank-
ing regions, the logged enrichment values of 5% of the outlying residuals (approximately 1200
highest and lowest outliers) and the residuals closest to 0 (5% of inliers) were analysed for
patterns in their Gene Ontology (GO) terms.113 Hypergeometric tests were used to look for
over-enriched GO terms in the outlying and inlying genes of the transcription-factors containing
model and the optimal model of the gene and flanking logged enrichments. Hypergeometric
testing was performed on the outliers and the inliers to assess any over-representation in GO
terms within these sets of genes. This was performed using the GOstats package provided by
Bioconductor114 in the R statistical program.112
The inlying and outlying genes were also compared to genes that are known to be important
to macrophage development taken from Ravasi et al.115 (table 2.2).
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Gene Function Gene Function
ATF3 Regulation of inflammatory re-
sponse
MYC Determination of macrophage
type
BCL3 Transcriptional co-activator NCOA3 Macrophage differentiation
BCL6 Transcriptional repressor NCOR1 Inflammatory Regulation
CEBPA Role in hematopiesis, immune
response
NCOR2 Inflammatory Regulation
CEBPB Regulates genes for im-
mune/inflammatory response
NFE2L2 Oxidative Stress Resistance
CEBPD Regulates genes for im-
mune/inflammatory response
NFKB2 Macrophage differentiation
and immune response
CITED2 Transcriptional repressor NFKB1 Macrophage differentiation
and immune response
CREB1 Response to hormonal stimu-
lation
NFKBIA Macrophage differentiation
and immune response
DDIT3 IL-6 regulation NR1H2 Inflammatory gene expression
EGR1 Macrophage differentiation,
adhesion, Phagocytosis
NR1H3 Inflammatory gene expression
EGR2 Macrophage differentiation,
adhesion, Phagocytosis
NR3C1 Inflammatory Regulation
ELF1 Macrophage-specific gene ex-
pression
p65 (RELA) Inflammatory Regulation
EP300 Endotoxin-stimulated gene ex-
pression
POU2F2 Immune Response
ETS2 Immune Response PPARG Determination of macrophage
type
FOS Macrophage differentiation Pu1 (SPI1) Macrophage differentiation
and immune response
FOSL1 Macrophage differentiation RARA Macrophage differentiation
FOXO3A Apoptosis RB1 Macrophage differentiation
GFI1 Endotoxin Tolerance RELB Immune Response
HDAC1 Growth, immune response RUNX1 Regulated growth and survival
HDAC3 Growth, immune response RXRA Macrophage differentiation
HIF1A Tumor Response RXRB Macrophage differentiation
HSF1 Immune Response SP1 Immune Response
IRF1 Immune Response SP3 Immune Response
IRF2 Immune Response STAT1 Tumor Response
IRF3 Immune Response STAT3 Immune Response
IRF5 Immune Response STAT5A Immune Response
IRF7 Immune Response STAT5B Immune Response
JUN Immune Response STAT6 Immune Response
JUNB Immune Response TFE3 Macrophage differentiation
JUND Immune Response TFEC Macrophage-specific gene
regulation
KLF4 Determination of macrophage
type
TRIM28 Macrophage differentiation
MAFB Macrophage differentiation YY1 Inflammatory response
MITF Immune Response
Table 2.2: A list of genes known to be important to the development or function of mouse
macrophage cells taken from Ravasi et al.115
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2.2.5 Drop Analysis
The effect of the transcription factors on the linear model results was investigated by comparing
the best model containing transcription factors to a similar model with one of the transcription
factors removed. This was done for CEBPα, p65 and Pu1, of pairs of the transcription factors,
and removing all three transcription factors from the model. The gene and flanking logged
enrichment model containing the transcription factors was used as the base model from which
the transcription factor was removed. The two linear models were then compared to identify
the genes that were affected the most and least by the removal of the transcription factor.
These genes were then investigated as to whether they were known or likely targets for the
transcription factor.
Predicting Transcription Factor Binding Sites
Relationships between most/least affected genes and transcription factors was investigated
through transcription factor binding site prediction and comparison to conserved binding sites.
MSigDB is a database of annotated gene sets.116 The C3 set of MSigDB (a set of cis-regulatory
motifs that are conserved between Human, Rat, Mouse and Dog genomes) was used to com-
pare genes that were affected by the model minus the transcription factor(s) to genes that are
known to be bound by these transcription factors.
MOODS61 was used to predict the binding sites for the transcription factors across the
whole of the genome using the consensus sequences from JASPAR.59 MOODS uses position-
weight matrices provided from JASPAR to find the most significant sub-matrix of the motif.
This sub-matrix represents the most likely core of the binding motif. MOODS then searches
across the genome to identify any location where this sub-matrix is found. The identified sub-
matrix is then extended and scored using log-odds against a background distribution.59 The
distribution of the p-values for any predicted binding sites located between the start and end of
the gene/flanking region were then compared to the genes that were most and least affected
by the removal of the transcription factor(s) from the model and 2000 randomly selected genes.
The consensus sequences used are shown in figure 2.2.
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(a) Consensus sequence for the DNA binding site of CEBPα from JASPAR. 59
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(b) Consensus sequence for the DNA binding site of p65 from JASPAR. 59
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(c) Consensus sequence for the DNA binding site of Pu1 from
JASPAR. 59
Figure 2.2: Binding motifs from JASPAR59 used in the prediction of binding sites.
32
2.3 Results
2.3.1 Linear Models
To investigate and develop a mechanistic hypothesis regarding the occurrence of RNA poly-
merase binding, linear models were used to fit the logged enrichment data for the histone
modification, transcription factor and DNase I hypersensitivity to the RNA polymerase II data.
RNA polymerase II binding was used as a measure of transcription on the assumption that
the more RNA polymerase II that is bound, the more RNA will be produced. Data from RNA
polymerase II ChIP-Seq experiments has been shown previously to correlate with expres-
sion data.74;105 Although not always equal, the amount of RNA that is produced is normally
a good indication of the amount of protein produced. The predictors (the transcription fac-
tors, histone modifications and DNase I hypersensitivity) were eliminated using a backward
elimination method, whereby the most non-significant (lowest p-value) predictor was removed
from the model. These models were checked by building a forward addition method, where
predictors with the most positive influence were added incrementally to an empty model; this
gave the same result. p-values were not used to evaluate the quality of the model as with
such a large dataset a small p-value can still result in a large number of badly predicted points.
Instead a combination of the adjusted-R2, f-statistic and Bayesian Information Criterion (BIC)
were used. The adjusted-R2 shows the amount of variance in the RNA polymerase II data that
can be explained by the model. The f-statistic and BIC give an indication as to whether the
model is losing (or gaining) information relative to the number of predictors in the model. The
linear models were designed in order to find the simplest model that could explain the majority
of the variance in the RNA polymerase II data while using the fewest number of predictors.
A simple model allows us to eliminate the genes which are easily predicted as transcribed or
not. The genes for which the model does not work can be highlighted as genes which may use
other mechanisms which the simple model does not account for.
The optimal model for the logged enrichments for the gene and flanking data was one com-
prising of just DNase I hypersensitivity, H3K4Me1 and H3K4Me3 (table 2.3). This model had
an adjusted-R2 of 0.7832 and a BIC of 50564. The adjusted-R2 was lower than a model that
contained H3K4Me3, H3K4ME1, DNase I hypersensitivity, p65, Pu1 and CEBPα, which had
an adjusted-R2 of 0.7911, but had a larger BIC. This indicates that the information contained in
the majority of the datasets is not necessary for predicting the binding of RNA polymerase II.
The increased BIC in the more complex model shows that the smaller model still retains the in-
formation needed to predict the binding. It is interesting that the optimal model for the gene and
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Model Adjusted-R2 p-value f-statistic Predictors
withheld
BIC
PolII ∼ CEBPα + CEBPβ
+ DNase + H3K4Me3 +
BCL6 + IgG + p65 +
H3K4Me1 + Pu1
0.7917 2.2x10−16 9655 on 9
and 22856
DF
51564
PolII∼CEBPα + DNase +
H3K4Me3 + BCL6 + IgG +
p65 + H3K4Me1 + Pu1
0.7916 2.2x10−16 1.086x10−4
on 8 and
22857 DF
-CEBPβ 50908
PolII ∼ CEBPα + DNase
+ H3K4Me3 + IgG + p65
+ H3K4Me1 + Pu1
0.7913 2.2x10−16 1.239x10−4
on 7 and
22858 DF
-CEBPβ,
BCL6
51101
PolII ∼ CEBPα + DNase
+ H3K4Me3 + p65 +
H3K4Me1 + Pu1
0.7911 2.2x10−16 1.443x10−4
on 6 and
22859 DF
-CEBPβ,
BCL6, IgG
51243
PolII ∼ CEBPα + DNase
+ H3K4Me3 + H3K4Me1
+ Pu1
0.7895 2.2x10−16 1.716x10−4
on 5 and
22860 DF
-CEBPβ,
BCL6, IgG,
p65
51165
PolII ∼ CEBPα + DNase
+ H3K4Me3 + H3K4Me1
0.7864 2.2x10−16 2.120x10−4
on 4 and
22861 DF
-CEBPβ,
BCL6, IgG,
p65, Pu1
50738
PolII ∼ DNase +
H3K4Me3 + H3K4Me1 +
Pu1
0.7876 2.2x10−16 2.120x10−4
on 4 and
22861 DF
-CEBPβ,
BCL6,
IgG, p65,
CEBPα, Pu1
50717
PolII ∼ DNase +
H3K4Me3 + H3K4Me1 +
p65
0.7838 2.2x10−16 2.072x10−4
on 4 and
22861 DF
-CEBPβ,
BCL6, IgG,
CEBPα, Pu1
50708
PolII ∼ DNase +
H3K4Me3 + H3K4Me1
0.7832 2.2x10−16 2.753x10−4
on 3 and
22862 DF
No Tran-
scription
factors
50701
PolII ∼ CEBPα + Pu1 +
p65
0.4797 2.2x10−16 7029 on 3
and 22862
DF
Transcription
factors from
the second
best model
only
71575
Table 2.3: Analysis of the Linear models containing different combinations of the predictors for
the flanking regions and gene region logged enrichments.
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flanking data doesn’t employ any of the transcription factor data as a predictor. More complex
models, such as ones containing CEBPα, DNase, H3K4ME3, H3K4Me1, p65 and Pu1, have
a slightly higher correlation with the RNA polymerase II logged enrichments than the simpler
model but result in a higher BIC. Comparing the models that contain transcription factors, the
optimal model (with CEBPα, with p65, with Pu1 or with all three of these transcription factors)
shows that their addition does not lead to a significant improvement in the correlation of the
model compared to the simpler model. The models with p65, Pu1 or CEBPα have adjusted-R2
of 0.7838, 0.7876 and 0.7864 respectively. Compared to the adjusted-R2 of 0.7832 in the sim-
ple model, there isn’t a large enough increase in the correlation to warrant choosing a complex
model over a simpler model with fewer predictors, a comparable adjusted-R2 and a smaller
BIC.
Model adjusted-R2 p-value f-statistic Predictors
withheld
BIC
PolII ∼ CEBPα + CEBPβ
+ DNase + H3K4Me3 +
BCL6 + IgG + p65 +
H3K4Me1 + Pu1
0.7708 2.2x10−16 8474 on 9
and 22666
DF
51986
PolII∼CEBPα + DNase +
H3K4Me3 + BCL6 + IgG +
p65 + H3K4Me1 + Pu1
0.7708 2.2x10−16 9531 on 8
and 22667
DF
-CEBPβ 51405
PolII∼CEBPα + DNase +
H3K4Me3 + IgG + BCL6 +
H3K4Me1 + Pu1
0.7706 2.2x10−16 1.088x10−4
on 7 and
22668 DF
-CEBPβ,
p65
50830
PolII ∼ CEBPα + DNase
+ H3K4Me3 + IgG +
H3K4Me1 + Pu1
0.7702 2.2x10−16 1.267x10−4
on 6 and
22669 DF
-CEBPβ,
BCL6, p65
50682
PolII ∼ CEBPα + DNase
+ H3K4Me3 + H3K4Me1
+ Pu1
0.7686 2.2x10−16 1.507x10−4
on 5 and
22670 DF
-CEBPβ,
BCL6, IgG,
p65
50649
PolII ∼ DNase +
H3K4Me3 + H3K4Me1
0.7626 2.2x10−16 1.850x10−4
on 4 and
22671 DF
-CEBPβ,
BCL6, IgG,
p65, DNase
50647
PolII ∼ H3K4Me3 +
H3K4Me1 + Pu1
0.7563 2.2x10−16 2.346x10−4
on 4 and
22672 DF
-CEBPβ,
BCL6, IgG,
p65, DNase,
CEBPα
50651
Table 2.4: Analysis of the Linear models containing different combinations of the predictors for
the Gene region logged enrichments.
The optimal model for the logged enrichments of the gene data is a model comprised
DNase I hypersensitivity, H3K4Me3 and H3K4Me1 (table 2.4). This model was close in both
adjusted-R2 and BIC to a model comprising of H3K4Me3, H3K4Me1 and Pu1. The model
containing DNase as opposed to Pu1 is superior in that it has a marginally better adjusted-
R2 and a lower BIC compared the Pu1-containing model. It is interesting, but not surprising,
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to note that the optimal model for the gene data is the same for the gene and flanking data,
though the steps used to get to each of the models differ. This is likely because the gene and
flanking data is largely the gene data, so the best models for each are likely to be similar.
Model adjusted-R2 p-value f-statistic Predictors
withheld
BIC
PolII ∼ CEBPα + CEBPβ
+ DNase + H3K4Me3 +
BCL6 + IgG + p65 +
H3K4Me1 + Pu1
0.7026 2.2x10−16 4161 on 9
and 15844
DF
48690
PolII ∼ CEBPα + CEBPβ
+ DNase + H3K4Me3 +
BCL6 + IgG + H3K4Me1
+ Pu1
0.7024 2.2x10−16 4678 on 8
and 15845
DF
-p65 45229
PolII ∼ CEBPα + CEBPβ
+ DNase + H3K4Me3 +
BCL6 + H3K4Me1 + Pu1
0.7023 2.2x10−16 5343 on 7
and 15846
DF
-p65, IgG 45214
PolII ∼ CEBPα + DNase
+ H3K4Me3 + BCL6 +
H3K4Me1 + Pu1
0.7020 2.2x10−16 6225 on 6
and 15847
DF
-p65, IgG,
CEBPβ
45209
PolII∼CEBPα + DNase +
H3K4Me3 + BCL6 + Pu1
0.7017 2.2x10−16 7460 on 5
and 15848
DF
-p65, IgG,
CEBPβ,
H3K4Me1
45203
PolII ∼ CEBPα + DNase
+ H3K4Me3 + Pu1
0.7013 2.2x10−16 9305 on 4
and 15849
DF
-p65, IgG,
CEBPβ,
H3K4Me1,
BCL6
45201
PolII ∼ CEBPα + DNase
+ Pu1
0.6282 2.2x10−16 8930 on 4
and 15850
DF
-p65, IgG,
CEBPβ,
H3K4Me1,
BCL6,
H3K4Me3
45205
Table 2.5: Analysis of the Linear models containing different combinations of the predictors for
the flanking regions logged enrichment.
The optimal model for the flanking region (table 2.5) was a model containing CEBPα,
DNase I hypersensitivity, H3K4Me3 and Pu1 as it had the lowest BIC. It is interesting that
the models for all of the datasets contain both DNase I hypersensitivity and the H3K4Me3 hi-
stone modification, indicating that it is likely that these two predictors are a good indication of
RNA polymerase II binding. H3K4Me3 is known to be linked with the activation of transcription.
DNase I hypersensitivity is indicative of the DNA uncoiling from the histones and the tighter
chromatin structure, which exposes it to allow RNA polymerase II binding.
Overall, the best result from using the linear models to predict the binding of RNA poly-
merase II was from the model using both the gene and flanking data (figure 2.3, residuals in
figure 2.4). This model had a higher adjusted-R2 than the models for the gene or flanking
data, as well as a lower BIC, indicating a greater amount of information relative to the num-
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ber of predictors and a better correlation with the RNA polymerase II binding data. The data
which combines the flanking and gene regions together potentially has more information than
looking exclusively at the gene or flanking regions. Transcription factors tend to have binding
sites withing the flanking/promoter region, while histones markers, DNase I hypersensitivity
and RNA polymerase II binding tend to occur between the transcription start and end sites
(the gene region).
Figure 2.3: The optimal linear model for the logged enrichment of the flanking and gene
data. The optimal model predicted RNA polymerase II binding using DNase I hypersensitivity,
H3K4Me3 and H3K4Me1 presence. Adjusted-R2=0.7832. p-value=2.2x10−16. BIC=50564
37
Figure 2.4: The residuals of the linear model predicting the log enrichment values for RNA
polymerase II enrichment using H3K4Me3, H3K4Me1, DNase I hypersensitivity, CEBPα, p65
and, Pu1. Adjusted-R2= 0.7911, p-value=2.2x10−16, f-statistic=1.443x10−4, BIC=50738.
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Figure 2.5: The residuals for only the macrophage-specific genes as detailed in table 2.2 for
the logged enrichment linear model, using the gene and flanking regions, using H3K4Me3,
H3K4Me1, DNaseI hypersensitivity, CEBPα, p65 and Pu1.
Looking at the residuals for the genes that have a specific relation to macrophage cells
(table 2.2) it is clear that there is a spread of genes throughout the range of predicted values;
the pattern of predicted enrichment values neither stands out as being consistently well pre-
dicted or consistently poorly predicted (figure 2.5). The genes that have a positively predicted
enrichment value (i.e. are predicted to be expressed) are predicted better than those with a
negative predicted enrichment value (i.e. genes predicted to not be expressed), as evidenced
by the much tighter clustering on the right of figure 2.5. This is likely due to the amount of
noise present in the negative enrichment values; any true signal is likely to be affected more
by the background noise in the ChIP-seq data. While it is disappointing that the residuals
for the macrophage-specific genes are not more tightly clustered along the 0-line, the point
at which the predicted value matches the actual enrichment value of the RNA polymerase II
data, the genes are all predicted reasonably well, and the majority lie well within the bulk of
the residuals. The reason that the macrophage-related genes are not predicted better is likely
due to the models being trained on all of the genes, and not just this subset of genes. Con-
structing the model using all of of the genes, rather than ones specific to a certain function,
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means that the model is optimised to predict the enrichment values of any gene in general. It
is likely that if the models were trained on a subset of the genes, such as the macrophage-
related genes, it would perform better at predicting these types of genes or genes that had a
similar transcription-regulatory mechanism, than genes with different regulatory mechanisms
or functions. While it would be interesting to do this, it is often statistically unfeasible to do due
to the small numbers of genes in these subsets.
2.3.2 Analysis of the Inliers and Outliers
The 5% of genes with the largest positive or negative residuals (outliers) and the 5% of genes
with the smallest residuals (inliers) for the model predicting RNA polymerase II logged en-
richment using H3K4Me3, H3K4Me1, DNase I hypersensitivity, CEBPα, p65 and Pu1 were
analysed for patterns. The aim of this further analysis was to investigate which genes the
model worked poorly for, with the intention of identifying macrophage-specific genes, functions
or processes that the model predicted poorly. Being able to identify the genes for which the
model doesn’t work will give us insight into any biological processes or events which are not
accounted for by the limited number of predictors used in the model.
Firstly, the genes found in these two sets were compared to a set of genes known to be
specifically relevant to macrophages115 and from genes known or predicted to be bound by
the transcription factors in the MSigDB database.116 There were no genes found in the inliers
or outliers present in either of these macrophage-relevant genes.
Hypergeometric testing was used to determine whether there was any over-enrichment of
any GO terms, with the intention of highlighting any specific process, function or localisation
for which the model was a poor predictor. Table 2.6 shows the results of the hypergeometric
testing. For the outlying genes, there were a total of 11 significantly enriched (adjusted p-
value < 0.001) GO terms, seven in the molecular function ontology, three in the biological
process ontology and one in the cellular component ontology. Four of the seven molecular
function enriched GO terms were related to DNA binding and, the other three were peptidase
or peptidase inhibitor activity related. Overall, the outliers show no macrophage or immune-
specific over-enrichment of GO terms.
For the inlying genes, there were a total of 10 significantly enriched (adjusted p-value <
0.001) genes: one in the molecular function ontology, none in the biological process ontology,
and nine in the cellular component ontology. All nine of the over-enriched GO terms were
interconnected and revolved around the over-enrichment of the membrane-bound organelle
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term. As with the outlying genes, there was no over-representation of any macrophage or
immune-specific GO terms.
Outliers
GO ID GO Term Ontology p-value
GO:0006366 transcription from RNA polymerase II promoter BP 4.31x10−5
GO:0006357 regulation of transcription from RNA polymerase II
promoter
BP 1.01x10−4
GO:0006355 regulation of transcription, DNA-dependent BP 9.37x10−4
GO:0005576 extracellular region CC 2.97x10−11
GO:0043565 sequence-specific DNA binding MF 2.02x10−11
GO:0003700 sequence-specific DNA binding transcription factor
activity
MF 1.11x10−10
GO:0001071 nucleic acid binding transcription factor activity MF 1.19x10−10
GO:0003677 DNA binding MF 2.01x10−6
GO:0030414 peptidase inhibitor activity MF 3.49x10−4
GO:0004866 endopeptidase inhibitor activity MF 6.50x10−4
GO:0008236 serine-type peptidase activity MF 9.94x10−4
Inliers
GO ID GO Term Ontology p-value
GO:0005488 binding MF 6.16x10−6
GO:0005623 cell CC 1.91x10−9
GO:0044464 cell part CC 2.92x10−9
GO:0005622 intracellular CC 7.74x10−9
GO:0044424 intracellular part CC 5.27x10−8
GO:0043231 intracellular membrane-bounded organelle CC 1.72x10−5
GO:0043227 membrane-bounded organelle CC 2.15x10−5
GO:0043229 intracellular organelle CC 4.48x10−5
GO:0043226 organelle CC 5.83x10−5
GO:0005737 cytoplasm CC 1.65x10−4
Table 2.6: The over-represented GO terms from the genes with the 5% largest (outliers) and
5% smallest (inliers) for the linear model predicting the logged enrichment values of RNA poly-
merase II using H3K4Me3, H3K4Me1, DNase I hypersensitivity, p65, Pu1 and CEBPα logged
enrichments as predictors. The GO ontologies are: BP (Biological Process), CC (Cellular
Component) and MF (Molecular Function).
Overall, the best-fit and worst-fit genes for the model appear to have no over-enrichment
for macrophage-specific genes. This could be due to the number of genes in the analysis
masking the location of the macrophage-specific genes under genes that are modelled less
well for unknown reasons.
2.3.3 Drop Analysis on linear model
The best model produced was a model that contained no transcription factors. This is in-
teresting as transcription factors are essential for the activation of genes and are ultimately
responsible for the modifications to the histones; their absence is therefore noteworthy. The
effect of each transcription factor on the model was looked at in more depth. Using the model
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containing H3K4Me3, H3K4Me1, DNase I hypersensitivity, Pu1, p65 and CEBPα as a base-
line, each of the transcription factors were then removed in turn. The two models - with and
without the transcription factors - were then compared to see which genes were affected the
most by the change. For example, CEBPα was removed and this model was compared to
a model only containing H3K4Me3, H3K4Me1, DNase I hypersensitivity, Pu1 and p65. The
genes most and least affected by this change were then studied further for any patterns in
the genes themselves and any potential transcription factor binding sites for the transcription
factor that was removed.
When a comparison was made between the genes most affected by the removal of each
transcription factor and the genes known to be important for macrophage development and
function (table 2.2) there were no matching genes. When compared to a set of genes from
MSigDB116 for which it is known that each transcription factor is bound there were also no
matches between the two lists of genes. The genes that were shown to be affected most, and
least, by the removal of a transcription factor where then analysed further to see if they had
the potential to be targets for the transcription factor in question.
When each of the transcription factors were removed from the model, the distribution of
the p-values for the gene binding sites that were affected the most by the change showed
very little difference when compared to the distributions for the least affected genes and 2000
random genes (figure 2.6). This observation was repeated when pairs of the transcription
factors were dropped (figure 2.7) and when all three transcription factors dropped (figure 2.8)
and the distributions of the transcription factors compared.
The very strong similarity between the distributions of the p-values for predicted binding
sites for the affected and unaffected genes with the random genes for all the models, re-
gardless of how many transcription factors were removed, indicated that they add no extra
information to the model beyond the histone modifications and DNase I hypersensitivity. The
transcription factors failing to add any more information beyond the histone modifications could
be the result of several conditions. The transcription factors, having bound to the DNA, are
what cause the histones to be modified and thus become accessible to RNA polymerase II.
This dependency of these modifications on transcription factors could mean that the effect of
the transcription factors is being masked by the stronger statistical effect of the histone modi-
fications in the model. Equally, it could be that the transcription factors are only able to bind in
the same regions that the histone modifications are in because of the modifications. This again
would statistically mask the effect the transcription factors have on the binding of RNA poly-
merase II. The statistical redundancy of the transcription factors and the histone modifications
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has been noted recently.117
(a)
(b)
(c)
Figure 2.6: Comparison between the MOODS61 predicted transcription factor binding sites
the genes that were affected the most (blue) and least when (a) CEBPα, (b) p65, and (c)
Pu1 were removed from the best transcription factor-containing linear model. The green line
indicates the distribution of the p-values of the binding sites within 2000 randomly selected
genes. Concensus sequences for each transcription factor were provided by JASPAR.59
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(a) (b)
(c) (d)
(e) (f)
Figure 2.7: Comparison between the MOODS61 predicted transcription factor binding sites
for genes that were affected the most (blue) and least (red) when pairs of transcription fac-
tors were removed from the best transcription factor-containing model. The green line indi-
cates the distribution of of the p-values of the binding sites within 2000 randomly selected
genes.Concensus sequences for each transcription factor were provided by JASPAR.59 (a)
Distribution of CEBPα binding sites when CEBPα and p65 were removed from the model. (b)
Distribution of p65 binding sites when CEBPα and p65 were removed from the model. (c)
Distribution of CEBPα binding sites when CEBPα and Pu1 were removed from the model. (d)
Distribution of Pu1 binding sites when CEBPα and Pu1 were removed from the model. (e) Dis-
tribution of p65 binding sites when Pu1 and p65 were removed from the model. (f) Distribution
of Pu1 binding sites when Pu1 and p65 were removed from the model.
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(a)
(b)
(c)
Figure 2.8: Comparison between the MOODS61 predicted transcription factor binding sites for
genes that were affected the most (blue) and the least (red) when all three transcription factors
were removed from the best transcription factor-containing model. The green line indicates
the distribution of the p-values of the binding sites within 2000 randomly selected genes. Con-
census sequences for each transcription factor were provided by JASPAR.59 (a) Distribution
of CEBPα binding sites when CEBPα, Pu1 and p65 were removed from the model. (b) Dis-
tribution of p65 binding sites when CEBPα, Pu1 and p65 were removed from the model. (c)
Distribution of Pu1 binding sites when CEBPα, Pu1 and p65 were removed from the model.
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2.3.4 Stratification
With the intent of determining if there is a difference between the genes with a high versus a
low enrichment value, the data were split in several ways to investigate the different models
for each subset of data. For the analysis, the data were split in three ways (figure 2.9). Firstly,
the RNA polymerase II data is clearly bimodal and was divided as such. The genes with
high expression were described as everything above -0.7 and the genes with low expression
as having a log enrichment value ≤ -0.7. Secondly, the data was split into high and low
expression genes: high expression genes as those above 0 and low expression as those with
a log enrichment value ≤ 0. It is important to note that an enrichment value below 0 means
that there are fewer reads for the gene in the RNA polymerase II data than in the background
metric that was used to calculate the enrichment; this is a good indicator that the gene is
hardly expressed or not expressed at all. The final two analyses of these sub-sets of data
were similar to the previous ones, the genes with low expression were regarded as those with
a RNA polymerase II log enrichment value ≤ 0. The genes with a log enrichment value above
0 were split into two subsets, the first were the genes with medium expression (as those with
a log enrichment value between 0 and 1.75) and the genes with high expression (those with
a log enrichment value above 1.75) for the first of the two analyses. The second of these
final two analyses took the genes with medium expression (those with log enrichment scores
between 0 and 2) and the genes with high expression (those with log enrichment scores over
2). The first of these final two sub-sets uses the medium-high boundary so that it splits the
number of genes that have a log enrichment value above 0 in to two equal sections, whilst the
second medium-high boundary is based on splitting the region above 0 in to two by value.
Limits Optimal Model R2 BIC
High >-0.7 PolII ∼ CEBPα + DNase I HS + H3K4Me3 0.6339 25100
Low <-0.7 PolII ∼ CEBPα + CEBPβ + DNase I HS +
H3K4Me3 + p65 + H3K4Me1 + Pu1
0.3040 14004
High >0 PolII ∼ H3K4Me3 + DNase I HS + Pu1 0.6021 17628
Low <0 PolII ∼ CEBPβ + DNase I HS + H3K4Me3
+ H3K4Me1
0.4306 21524
High >2 PolII ∼ CEBPα + H3K4Me3 + DNase I HS
+ Pu1
0.3651 1714
Med <2 & >0 PolII ∼ H3K4Me3 + DNase I HS + Pu1 0.3737 11400
High >1.75 PolII ∼ H3K4Me3 + DNase I HS + Pu1 0.4154 2727
Med <1.75 & >0 PolII ∼ H3K4Me3 + DNase I HS + Pu1 0.3245 8823
All Data Model None PolII ∼ H3K4Me3 + H3K4Me1 + DNase I
HS
0.7832 50564
Table 2.7: Models for the stratified data using various groupings of genes.
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Figure 2.9: Distribution of the log enrichment values for the RNA polymerase II dataset. a-d
indicate the ranges used for training models on subsets of this data. The cut-off at a, -0.7,
was based on the lowest point of the bimodal distribution. The cut-off for b is based anything
below 0 being less than the background noise. c and d split the region above 0 into two. For
c, the cut-off is at 2, which arbitrarily assigned as approximately halfway between 0 and the
maximum value. For d, the cut-off is at 1.75, which splits the number of genes above 0 into
two equal groups.
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Comparing the cut-offs for genes with high or low expression shows that it is better taking
a cut-off based on the two distributions rather than at 0. This is likely due to a statistical, rather
than a biological, reason as using a distribution-based cut-off means that more of the signal
from the distribution is included in the modeling and produces a better model. Irrespective of
this, using 0 or -0.7 as the cut-off for a gene having high or low expression both produce a
similar model. The genes classed as having low expression are predicted poorly, with an R2 of
0.30 and 0.43 using -0.7 and 0, respectively. The genes classed as having high expression are
better predicted by the model , with R2 values of 0.63 and 0.60 using -0.7 and 0, respectively.
These higher expressing genes are able to be predicted better by the model because the
majority of the information in this region is likely to be actual signal, rather than noise. This
means that the model is fitting to, and predicting, the binding of the RNA polymerase II rather
than to background noise. Any gene with a log enrichment below 0 has an enrichment value
that is below the background noise selected for that region. This means that the modeling for
the genes with low expression is being attempted with data with is dominated by background
noise, explaining why the models perform poorly. It is interesting to note that when the region
above 0 is split into two, regardless of the two cut-offs used, that the models produced perform
similarly, but not as well as taking the region as a whole. This is most likely due to the models
being produced using “blunt” predictors. All of the models for genes with a log enrichment
above 0 result in the same model; RNA polymerase II ∼ H3K4Me3 + DNase I Hypersensitivity
+ Pu1. This model is very interesting as it comprises a histone modification that is known to be
strongly indicative of active genes, the DNase I hypersensitivity data which indicates whether
the genes are open to be bound by RNA polymerase II, and a transcription factor that plays
a large role in the development and maintenance of macrophage function. All three of these
predictors are likely to have a fairly coarse-grained effect on gene transcription. None of them
are involved in the fine-grained regulation of expression, possibly explaining why the model
performs better over a larger range rather than arbitrarily splitting the expressed genes into
small sets.
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2.4 Discussion
Overall, this work shows that using a simple measure based on read-counts from ChIP-seq
data, combined with a simple linear model, it is possible to predict the level of RNA polymerase
II binding in mouse macrophage cells. The best model produced using this data was one only
containing DNase I hypersensitivity and the histone modifications, H3K4Me3 and H3K4Me1.
The lack of the presence of transcription factors indicates that there is a redundancy, at least in
a statistical sense, between transcription factors and histone modifications/accessibility when
it comes to predicting RNA polymerase II binding. It is interesting to note that the addition of
three transcription factors, CEBPα, p65 and PuI had little improvement on the quality of the
model and the amount of variance in the RNA polymerase II binding data. Further analysis
of models containing transcription factors shows that their addition and the improvement upon
the simpler model has little to do with any biological relevance and is based on the model
having more datasets to optimise with. The comparison of models with and without tran-
scriptions factors show that the presence of the transcriptions factors generally affects genes
that have similarly predicted transcription factor binding sites as a random selection of genes.
Analysis of the subsets of the RNA polymerase II enrichment data shows it is far easier to
predict the level of RNA polymerase II binding in a broad sense, using these histone modifi-
cations/accessibility, but is less accurate when a smaller range of data is used. This is due to
the nature of the markers used and the limited amount of data available for the modeling. The
markers used for all of the models of the data with log enrichments above 0 were DNase I hy-
persensitivity, H3K4Me3 and PuI. These are fairly broad indicators of transcription; therefore
the wider the range of data used for the modelling, the better the model is. While the tran-
scription factors are important for the transcription of genes, Pu1 especially being an overall
regulator of macrophage differentiation and functional maintenance, they are general regula-
tors of transcription and the models miss the fine-grained control of the markers themselves
and their fine-grained control of transcription. The macrophage-related genes have their en-
richment values predicted fairly well by the models produce here. While ideally they would be
predicted well enough to be identified at some of the best-predicted genes, the model predicts
all of them well enough that none of them are present in the outlying genes. The models don’t
predict the macrophage-related genes better than any other set of genes as the models were
trained using all transcription factors. This means that the models are good at predicting tran-
scription factors in general in macrophage cells, rather than a specific sub-set of transcription
factors. This could be addressed by training the models on a sub-set of the genes, such as
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the macrophage-related genes or immune-response related genes, then tested on the rest of
the data. Doing this could potentially highlight sets of genes which have the same regulatory
mechanisms as the set of genes the model was trained on. In practice, this is not as simplistic
as it appears as there would need to be a large enough set of genes for the models to be
trained on and even having similar functions within the cell does not mean that the regulation
of their expression is managed using similar mechanisms. The investigation into the genes
that are predicted well or poorly (and thus are likely to have similar or dissimilar regulatory
mechanisms, respectively) is likely to be non-trivial due to the large numbers of genes. Re-
cent work has shown that there is a large amount of non-specific transcription factor binding
that does not affect transcription.118 While this was found in yeast, it is likely to hold true for
for higher eukaryotes and would go some way to explaining why the transcription factor data
added very little to the predictive power of the models over just using the histone modifications.
If this non-specific transcription factor binding does not influence gene expression, then the in-
formation about transcription factor binding that does have an effect on transcription is likely
to be masked behind the noise of the binding that doesn’t affect transcription. Given the large
number of transcription factor binding sites that ChIP-seq experiments find compared to the
number of transcribed elements in the genome, the likelihood that there are detected binding
sites that do not affect transcription is high.
While it is hard to compare the models constructed here to the models previously devel-
oped by Ouyang et al 74 and Cheng & Gerstein105 due to different aims of the models, a
comparison can be made. Ouyang et al used 12 transcription factors and principle component
analysis and were able to explain 70% of the variance in their response variable; expression
data from micro-array experiments. Cheng and Gerstein used 12 transcription factors and 7
histone modifications with support vector regression to explain 72% of the variance in their
response variable. The model developed here, using the simple enrichment values with linear
regression produced a final model of just 3 histone modifications, starting from 5 transcription
factors and 3 histone modifications, was able to explain 78% of the variance in the RNA poly-
merase II binding data. While the model constructed here can explain more of the variance in
the expression-metric used, and the comparison between the methods is interesting, it would
be unfair to say it performs better than the previous studies due to the different aims of the
methods. Ouyang et al were specifically using principle component analysis to find cooper-
ation between transcription factors, Cheng and Gerstein using the support vector regression
to look at differences in the special patterning of transcription factors and histone modifica-
tions - with note of the statistical redundancy between them - whist here the aim was to look
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more specifically at a mechanistic hypothesis for RNA polymerase II binding. The redundancy
between transcription factors and histone modifications, while not as clear as that found by
Cheng and Gerstein, is still evident in the results here. A significant difference between the
results here and Cheng’s is the histone modifications being dominant in the optimal models.
While the method developed here marginally out-performs the methods of Ouyang et al and
Cheng and Gerstein, it has makes assumptions each of the other methods try to address.
Ouyang et al, with their transcription factor association score, attempt to take into account
more distal transcription factor binding sites that may still have an influence on the expression
of a gene. Cheng and Gerstein, by using machine learning, do not make the assumption that
the relationship between the transcription factors and expression is a linear one; a method that
could potentially improve the models produced here. The method used here does, however,
encompass the different binding profiles of the histone modifications that is missed in method
of Cheng and Gerstein, and uses histone modification data that was not available to Ouyang
et al. This is likely one of the sources of improvement over their methods as it means that
more of the subtle interaction between the histone modifications and expression is used by the
models.
Using the simple metrics in this work has led to a good model for RNA polymerase II
binding. It is not, however, comprehensive. Due to only a small number of transcription factors
and histone modifications being used, a lot of the fine-grain detail has been lost and only a
broad, coarse-grained model is possible. The model produced uses factors that are known
to be strong indicators of gene transcription. The over-all mechanism of transcription factor
binding is simplified in the resulting model. With this small amount of data is is difficult to
investigate the more subtle interplay between the large variety of transcription factors that
control the regulation of RNA polymerase II binding.
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Chapter 3
Genetic Regulation in Human
Stem Cells
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3.1 Introduction
3.1.1 Importance of embryonic stem cells
Embryonic stem cells originate in the center of a fertilised egg prior to plantation and are
pluripotent cells with the potential to differentiate into any other cell type. They are obtained
from the central mass of an embryo before implantation, which normally occurs 4-5 days after
fertilisation of the egg. Embryonic stem cells not only have the ability to differentiate into any
other cell type but also have a limitless ability to self-renew.119 The pluripotency of embryonic
stem cells is unmatched in any other cell type, and it is this which makes them such an in-
teresting research target. The potential of the stem cells to develop into any other cell type,
and react quickly to any differentiation signals they receive, means that tight control must be
exerted over gene expression.
Whilst there are stem cells present in adults, they don’t have the total potential of embryonic
stem cells; for example bone marrow derived stem cells are unable to form cells of the central
nervous system. Embryonic stem cells are an important research target for pluripotency and
lineage commitment, but their source has caused some controversy. There is work being done
to convert adult stem cells into embryonic stem cell-equivalent cells, though there is a vast
amount of work to be done in this field.120 Research is being done into using stem cells to treat
a number of pathologies including diabetes,121 Parkinson’s,122;123 cancer,124 cardiovascular
disease,125 and Alzheimer’s disease.126
The capacity of embryonic stem cells to differentiate into any cell type, while retaining
full capacity for self-renewal, makes them an incredibly interesting research subject. We are
only beginning to understand their potential, how they function, and how they maintain their
pluripotency.
3.1.2 Transcriptional control of stem cells
There are three core transcription factors that exert the majority of the control over the pluripo-
tency and self-renewing characteristics of human and mouse embryonic stem cells: Oct4/Pou5F1,
Sox2 and Nanog.127
Oct4 is essential for pluripotency and is only expressed in pluripotent and totipotent cells.128;129
The level of Oct4 expression must be highly controlled as either over- or under-expression
leads to differentiation.52 Sox2 is also essential for pluripotency.130 Sox2 and Oct4 both reg-
ulate embryonic stem cell-specific genes, including themselves.131–139 The third of the core
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embryonic stem cell proteins, Nanog, is only required to form pluripotent cells.140 Once the
pluripotency is reached, cells in which Nanog has been silenced maintain pluripotency but are
more likely to spontaneously differentiate.141;142 Further evidence of the increased likelihood of
differentiation of Nanog-deficient cells is under conditions causing increased DNA damage. In
this situation, p53 suppresses expression of Nanog and results in a more differentiated state,
which in turn allows for p53-dependent cell cycle arrest and apoptosis.143;144
The core embryonic stem cell transcription factors are often found co-binding at active and
silent locations across the genome.145;146 There have been studies into the co-binding sites
of these core transcription factors which have highlighted various interesting targets, including
other genes required for pluripotency and the encoding of proteins required for the modification
of chromatin.147–154 The manner in which they repress and promote expression at each of
these locations is still poorly understood.
It has also been found that there is a second important set of transcription factors which
influence embryonic stem cells - the Myc cluster.155 The Myc cluster, which includes c-Myc,
n-Myc, Rex1, Zfx and E2f1, is thought to be independent of Oct4 regulation. It is known that
this cluster is involved in metabolism, as well as self-renewal.156–158 The extent of the binding
in this cluster is vast, with almost a third of all active embryonic stem cell genes bound by the
core transcription factors and c-Myc.159 It is thought that the core transcription factors work to
recruit the transcriptional machinery to the genes, while c-Myc is responsible for the control of
the pause-release of this machinery.159 Recent work, however, has postulated that the function
of the Myc cluster acts by amplifying the effect of genes that are already transcribed, rather
than activating new genes.160;161
Overall, the maintenance of pluripotency and limitless self-renewal is a fine balance be-
tween a large number of transcription factors and the action and expression of each being
under tight control by the master regulators, Oct4, Nanog and Sox2. While the exact function
and interaction of all the transcription factors in the cell is still unknown, much work is being
done in this field.
3.1.3 Histone modification control of stem cells
In embryonic stem cells, histone modifications are as tightly controlled as transcription factor
binding. Having the correct histone modifications in the appropriate places is essential for the
maintenance of pluripotency and self-renewal.
Generally, H3K4Me3 presence is directly related to RNA polymerase II binding and tran-
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scription.162 In embryonic stem cells this is not the case; most of the promoters across the
genome are marked with H3K4Me3, whether the gene they are associated with is transcribed
or not.163;164 The balance of methylation marks at lysine 4 of histone H3 is a delicate affair in
stem cells: while H3K4Me3 is present at most promoters it is often found alongside the repres-
sive H3K27Me3 modification which results in the gene being in a poised state.54 This poised
state very often occurs for genes that are essential for differentiation.54;55;165–167 The pres-
ence of the H3K27Me3 marker silences the locations bound by H3K4Me3 while the cell is still
pluripotent, but upon differentiation, one of the two markers is removed, leaving either an ac-
tive or silenced gene depending on the fate of the cell.54;55;165 The purpose of this combination
of activation and repression markers is thought to be to allow rapid response to differentiation
signals that the stem cell receives. The role of H3K27Me3 is complicated and still not en-
tirely clear. H3K27Me3 has been implicated in the poised state signalling,54;55;165 in regulating
pluripotency,168 and even cellular reprogramming,169 though its full role is still being studied.
The balance of H3K4Me mono-, di- and tri- methylation is essential for the careful maintenance
of stem cell physiology. Cells with a deficiency in H3K4Me1/2 specific de-methylases sponta-
neously differentiate170 and cells lacking H3K4Me2/3 specific de-methylases lose the ability to
self-renew.171
H3K9Me3, a long-range silencing marker, plays an important role in the regulation of stem
cell pluripotency. H3K9Me3 regions have been found to be much smaller, and the effect of its
long-range silencing increased,172 in stem cells as compared to differentiated cells.173 Despite
increased effects in differentiated cells, H3K9Me3 has been shown to regulate Oct4 down-
regulation by promoting DNA methylation of the Oct4 gene.174 The histone de-methylases
Kdm3a and Kdm4c regulate the H3K9Me3 marker: the loss of these proteins results in non-
reversible stem cell differentiation, highlighting the importance of this marker.175
H3K79 methylation is normally found within the gene body of actively transcribed genes.176
Depletion of Kmt4, the methyltransferase responsible for H3K79 methylation, in stem cells
results in a lower proliferation rate while maintaining pluripotency and self-renewal abilities.177
Interestingly, depletion of Kmt4 also results in more open chromatin due to the loss of two
histone modifications, H3K9Me2 and H4K20Me3, at the centromeres and telomeres177 as
well as increased expression of Nanog, though the mechanism for this is unclear.178
Histone acetylation opens up chromatin by neutralising the positive charge of the lysine
residues. Histone acetylation is very common in embryonic stem cells compared with differenti-
ated cells, highlighting the open nature of the chromatin in these embryonic stem cells.162;179–181
Inhibiting histone de-acetylases in stem cell results in cells with a reduced ability to differentiate
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and stronger self-renewal.182;183
3.1.4 ENCODE
The Encyclopedia of DNA Elements (ENCODE) builds on the work of the human genome
project. The human genome project sequenced the whole of the human genome for the first
time. While the objective of the human genome project was to sequence the DNA in a sin-
gle person, the objective of ENCODE is to find and characterise the functional elements of
the sequence.184 The human genome project paved the way for ENCODE, establishing a ref-
erence sequence. The established base is that ∼23000 protein-coding genes of the human
genome make up only 1.5% of the ∼3 billion base pairs. The aim of ENCODE is to estab-
lish the function of the rest of our DNA, which includes many regulatory elements, non-protein
coding elements and supposed "junk", non-functional, DNA. The first wave of publications from
the ENCODE project were released on the 5th of September 2012; at that point, there were
1640 datasets available from 147 different cell lines.185 The initial findings debunked the idea
of "junk" DNA, showing that 80% of the genome can be classified as having biological function
(protein/non-coding RNA or a reproducible biochemical signature). In at least one cell type,
95% of the genome is within 8kb of a protein-DNA interaction and 99% of it is within 1.7kb of
a “biochemical event”.185
Overall, the ENCODE project and the accessibility of the data it produced are a massive
step forwards in the understanding of the function of the human genome and a boon for the
scientific community.
3.1.5 Aims and Objectives
The aim of this chapter is to take the methods previously used on the mouse macrophage
data and apply them to a larger set of data derived from embryonic stem cells. Using the same
simple enrichment value, LASSO regression was used to construct models using 24 histone
modification and 23 transcription factor datasets. As previously, RNA polymerase II binding
was taken as an equivalent to gene expression levels; the correlation between the two has
been previously shown.74;75
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3.2 Methods
3.2.1 Data sets
The datasets used were obtained from the GEO database.106 All of the datasets used were
from ChIP-seq experiments. Data from the human embryonic cell line H1 (table 3.1) were
compared to data from the H9 (table 3.2) and IMR90 (table 3.3) stem cell lines. As per the
ENCODE requirements, all of these cell lines were grown in the same conditions and pre-
pared and sequenced in a similar manner. If the datasets were comparable, where a marker
appeared in multiple cell lines, the markers would be highly correlated in all cases and cluster-
ing would occur between identical markers of different cell lines, rather than within cell lines.
For the comparison of the datasets all available data were used, but for subsequent modelling
only used one dataset for each marker: the dataset with the highest number of reads. The
datasets were imaged and clustered using the default arguments for the heatmap function of
the R Statistical package.112 Models were constructed for all four of the RNA Polymerase II
datasets available for the H1 cell line. It was decided that modeling each RNA polymerase II
dataset was better than selecting one or taking some form of mean or consensus of the four
sets together. Analysing four models allows for a comparison of the models, giving a consen-
sus as to what predictors are eliminated and better overview as to the mechanistic hypothesis
for RNA Polymerase II binding. As there are multiple datasets for the same marker, only the
dataset with the most reads was used in the modelling stages. These datasets are indicated
by the entries in bold in table 3.1.
Accession Marker Marker Type
SRR351841 ATF3 Transcription Factor
SRR351842 ATF3 Transcription Factor
SRR351776 BALIIA Transcription Factor
SRR351628 BCLIIA Transcription Factor
SRR351670 CTCF Transcription Factor
SRR351671 CTCF Transcription Factor
SRR351691 EGR-1 Transcription Factor
SRR351692 EGR-1 Transcription Factor
SRR351600 FOSL1 Transcription Factor
SRR351601 FOSL1 Transcription Factor
Continued on next page.
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Accession Marker Marker Type
SRR351679 GABP Transcription Factor
SRR351680 GABP Transcription Factor
GSM602257 H2AK5ac Histone Modification
GSM602258 H2AK5ac Histone Modification
GSM605295 H2BK120ac Histone Modification
GSM605296 H2BK12ac Histone Modification
GSM605297 H2BK12ac Histone Modification
GSM605298 H2BK15ac Histone Modification
GSM605299 H2BK15ac Histone Modification
GSM605300 H2BK20ac Histone Modification
GSM605301 H2BK20ac Histone Modification
GSM605302 H2BK5ac Histone Modification
GSM605303 H2BK5ac Histone Modification
GSM602259 H3K18ac Histone Modification
GSM605304 H3K18ac Histone Modification
GSM667614 H3K18ac Histone Modification
GSM667615 H3K18ac Histone Modification
GSM667617 H3K23ac Histone Modification
GSM667618 H3K23ac Histone Modification
GSM605305 H3K23me2 Histone Modification
GSM605306 H3K23me2 Histone Modification
GSM466732 H3K27ac Histone Modification
GSM663427 H3K27ac Histone Modification
GSM434776 H3K27me3 Histone Modification
GSM466734 H3K27me3 Histone Modification
GSM605308 H3K27me3 Histone Modification
GSM409312 H3K36me3 Histone Modification
GSM450268 H3K36me3 Histone Modification
GSM466737 H3K36me3 Histone Modification
GSM605309 H3K36me3 Histone Modification
Continued on next page.
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Accession Marker Marker Type
GSM605311 H3K4ac Histone Modification
GSM667624 H3K4ac Histone Modification
GSM409307 H3K4me1 Histone Modification
GSM434762 H3K4me1 Histone Modification
GSM466739 H3K4me1 Histone Modification
GSM605312 H3K4me1 Histone Modification
GSM602260 H3K4me2 Histone Modification
GSM602261 H3K4me2 Histone Modification
GSM409308 H3K4me3 Histone Modification
GSM469971 H3K4me3 Histone Modification
GSM605315 H3K4me3 Histone Modification
GSM605317 H3K56ac Histone Modification
GSM667627 H3K56ac Histone Modification
GSM605318 H3K79me1 Histone Modification
GSM605319 H3K79me1 Histone Modification
GSM605320 H3K79me1 Histone Modification
GSM605321 H3K79me2 Histone Modification
GSM605322 H3K79me2 Histone Modification
GSM434785 H3K9ac Histone Modification
GSM605323 H3K9ac Histone Modification
GSM428291 H3K9me3 Histone Modification
GSM605325 H3K9me3 Histone Modification
GSM605327 H3K9me3 Histone Modification
GSM605328 H3K9me3 Histone Modification
GSM605329 H4K20me1 Histone Modification
GSM605330 H4K5ac Histone Modification
GSM605332 H4K91ac Histone Modification
SRR351523 HDAC2 Transcription Factor
SRR351524 HDAC2 Transcription Factor
SRR351876 JunD Transcription Factor
Continued on next page.
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Accession Marker Marker Type
SRR351877 JunD Transcription Factor
SRR351702 NANOG Transcription Factor
SRR351703 NANOG Transcription Factor
SRR351566 NRSF Transcription Factor
SRR351567 NRSF Transcription Factor
SRR351902 p300 Transcription Factor
SRR351903 p300 Transcription Factor
SRR351568 Pol II RNA Polymerase II
SRR351569 Pol II RNA Polymerase II
SRR351787 Pol II RNA Polymerase II
SRR351788 Pol II RNA Polymerase II
SRR351704 POU5F1 Transcription Factor
SRR351705 POU5F1 Transcription Factor
SRR351758 RAD21 Transcription Factor
SRR351759 RAD21 Transcription Factor
SRR351565 Rev X link Chromatin Transcription Factor
SRR351829 RXRA Transcription Factor
SRR351830 RXRA Transcription Factor
SRR351687 Sin3AK-20 Transcription Factor
SRR351688 Sin3AK-20 Transcription Factor
SRR351645 SIX5 Transcription Factor
SRR351646 SIX5 Transcription Factor
SRR351590 SP1 Transcription Factor
SRR351591 SP1 Transcription Factor
SRR351681 SRF Transcription Factor
SRR351682 SRF Transcription Factor
SRR351727 TAF1 Transcription Factor
SRR351728 TAF1 Transcription Factor
SRR351819 TAF7 Transcription Factor
SRR351820 TAF7 Transcription Factor
Continued on next page.
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Accession Marker Marker Type
SRR351685 TCF12 Transcription Factor
SRR351686 TCF12 Transcription Factor
SRR351683 USF-1 Transcription Factor
SRR351684 USF-1 Transcription Factor
SRR351843 YY1-(sc-281) Transcription Factor
SRR351844 YY1-(sc-281) Transcription Factor
Table 3.1: The datasets used for the generation of models for human H1 embryonic stem cell
line from the GEO database.106 Entries marked in bold were later used for the linear models.
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Accession Marker Marker Type
GSM605307 H3K27ac Histone Modification
GSM605310 H3K36me3 Histone Modification
GSM605314 H3K4me2 Histone Modification
GSM605316 H3K4me3 Histone Modification
GSM605324 H3K9ac Histone Modification
GSM616127 H3K4me2 Histone Modification
GSM616128 H3K4me3 Histone Modification
GSM616129 H3K9ac Histone Modification
GSM665037 H3K27ac Histone Modification
GSM667608 H2AK5ac Histone Modification
GSM667609 H2AK5ac Histone Modification
GSM667610 H2BK12ac Histone Modification
GSM667611 H2BK12ac Histone Modification
GSM667612 H2BK5ac Histone Modification
GSM667613 H2BK5ac Histone Modification
GSM667616 H3K18ac Histone Modification
GSM667619 H3K23ac Histone Modification
GSM667620 H3K23ac Histone Modification
GSM667621 H3K23me2 Histone Modification
GSM667622 H3K27me3 Histone Modification
GSM667623 H3K36me3 Histone Modification
GSM667625 H3K4ac Histone Modification
GSM667626 H3K4me1 Histone Modification
GSM667628 H3K56ac Histone Modification
GSM667629 H3K79me1 Histone Modification
GSM667630 H3K79me2 Histone Modification
GSM667631 H3K9me3 Histone Modification
GSM667632 H3K9me3 Histone Modification
GSM667633 H3K9me3 Histone Modification
GSM667634 H4K20me1 Histone Modification
GSM667635 H4K5ac Histone Modification
GSM667636 H4K5ac Histone Modification
GSM667637 H4K8ac Histone Modification
GSM667638 H4K8ac Histone Modification
GSM667639 H4K91ac Histone Modification
GSM667640 H4K91ac Histone Modification
GSM667643 Input Histone Modification
Table 3.2: The datasets used for the generation of models for human H9 embryonic stem cell
line from the GEO database.106
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Accession Marker Marker Type
GSM605307 H3K27ac Histone Modification
GSM605310 H3K36me3 Histone Modification
GSM605314 H3K4me2 Histone Modification
GSM605316 H3K4me3 Histone Modification
GSM605324 H3K9ac Histone Modification
GSM616127 H3K4me2 Histone Modification
GSM616128 H3K4me3 Histone Modification
GSM616129 H3K9ac Histone Modification
GSM665037 H3K27ac Histone Modification
GSM667608 H2AK5ac Histone Modification
GSM667609 H2AK5ac Histone Modification
GSM667610 H2BK12ac Histone Modification
GSM667611 H2BK12ac Histone Modification
GSM667612 H2BK5ac Histone Modification
GSM667613 H2BK5ac Histone Modification
GSM667616 H3K18ac Histone Modification
GSM667619 H3K23ac Histone Modification
GSM667620 H3K23ac Histone Modification
GSM667621 H3K23me2 Histone Modification
GSM667622 H3K27me3 Histone Modification
GSM667623 H3K36me3 Histone Modification
GSM667625 H3K4ac Histone Modification
GSM667626 H3K4me1 Histone Modification
GSM667628 H3K56ac Histone Modification
GSM667629 H3K79me1 Histone Modification
GSM667630 H3K79me2 Histone Modification
GSM667631 H3K9me3 Histone Modification
GSM667632 H3K9me3 Histone Modification
GSM667633 H3K9me3 Histone Modification
GSM667634 H4K20me1 Histone Modification
GSM667635 H4K5ac Histone Modification
GSM667636 H4K5ac Histone Modification
GSM667637 H4K8ac Histone Modification
GSM667638 H4K8ac Histone Modification
GSM667639 H4K91ac Histone Modification
GSM667640 H4K91ac Histone Modification
GSM667643 Input Histone Modification
Table 3.3: The datasets used for the generation of models for human IMR90 embryonic stem
cell line from the GEO database.106
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3.2.2 Enrichment Calculation
Enrichment values were calculated for each gene within each dataset using the same method
as described in section 2.2.2. The background values used in the calculation of the enrichment
value are as described in section 2.2.2. The enrichment values used are the number of reads
for the gene and flanking region (2000bp up and down-stream of the transcription start and
end sites) divided by a background value of reads per base multiplied by the length of the
gene and flanking region. For the background value we used the highest of the mean reads
per base for the whole of the dataset, the chromosome the gene was on or two 10,000bp
regions surrounding the gene/flanking region. As previously, for genes where the enrichment
value was 0, the value was set to 0.001 so that it was possible to take the log for the gene.
In this case only the gene and flanking regions together were considered for the enrichment
values. This was in part owing to the results of the previous chapter finding where using
regions together led to more robust results, and partly owing to the prevalence of the “paused”
histone state. This “paused” state occurs often in embryonic stem cells and is marked by the
occurrence of both the H3K4Me3 and H3K27Me3 modifications.54;163;164
3.2.3 Linear Models
Linear models were employed to fit and optimise the transcription factor and histone mod-
ification data to the RNA polymerase II binding data. Using linear models it is possible to
remove predictors from the model and re-run them. It is then possible to compare different
models to identify which of them are better at fitting to the RNA polymerase II binding data,
and thus are more likely to represent reality. Owing to the large number of datasets available,
the simple forward stepwise elimination of predictors is not a viable method for optimising a
linear model, due to the large number of possible combinations of predictors. For the model
selection, LASSO (least absolute shrinkage and selection operator) regression was used.186
LASSO regression is a regularised least-squares regression method that calculates a stan-
dard regression model (equation 3.1) with a restriction that the parameter vector (L1-norm) is
less than a tuning parameter (s, equation 3.2). LASSO regression is a method for selecting a
sub-set of predictors that result in the best fit for the response variable given the cutoff used.
Using this form of regression not only allows the removal of redundant datasets from the model
but also, in doing this, helps to avoid over-fitting to the response variable (RNA polymerase II
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binding in this case).
yi = β0 + β1xi1 + β2xi2 ...βpxip, i = 1, ... , n, (3.1)
min
∑
(y − yˆ)2 subject to
∑
|bp| ≤ s (3.2)
Where y is the observed data, x is the predictor, b the coefficient and s is the chosen tuning or
constraint parameter. As the model is calculated, choosing s, the constraint value, is equivalent
to choosing the number of predictors to be used in the final model.
Cross-validation was used to calculate the optimal constraint value for the dataset. Fifty-
fold cross-validation was used. The Least Angle Regression (LARS) algorithm187 was used
to perform the LASSO regression for each step of the cross-validation and the final constraint
value used was within one standard error of the mean. Using this constraint value allowed
elimination of the highest number of predictors, whilst retaining a reasonable degree of error.
65
3.3 Results
3.3.1 Comparison of Cell Lines
A comparison of all the available datasets for the H1, H9 and IMR90 cell lines was done to
assess whether the data from each cell line were comparable. The aim of this was to establish
whether the datasets were usable together so as to expand the data available for the later
modeling of RNA polymerase II binding. Figure 3.1 shows the correlation of the enrichment
values for each gene for all available data for these three cell lines. Here, it is obvious that
the datasets from IMR90 cells (green) are mostly clustered together, indicating that the IMR90
datasets correlate better with themselves rather than with identical markers from the other cell
lines. The clustering of the IMR90 datasets contradicts combining datasets from multiple cell
lines into a single linear model. A closer comparison of the H1 and H9 cell lines was required
to establish whether it was feasible to use a combination of the two cell lines in the modelling
stages (table 3.2). For the most part it appears that the data would be comparable, but there
is a significant amount of clustering of the H9 cell line data in one part of the plot. This cluster
together accounts for a third of the H9 datasets (13 of 37). While this cluster of H9 datasets
were correlated to some extent with a fair number of the H1 datasets it was decided that using
a single cell line would be the best approach in modelling the binding of RNA polymerase II so
as to avoid unnecessary noise or biologically irrelevant datasets to the data used in the models.
Figure 3.3 shows the correlation between the enrichment values for the histone modifications
of the H1 cell line data. The heat map shows the relationship between the modifications that
occurring on different histone sub-units and the various modifications which occur. It is evident
that the datasets available are enriched in modifications that occur on the H3 protein and that
there are a large number of acetylation datasets available. There is a fairly distinct correlation
between the majority of the acetylated markers (shown in orange). Figure 3.4 shows the
correlations of the enrichment values for the transcription factor datasets for the H1 cell line.
This figure shows clear correlations (red) between some transcription factors and also distinct
anti-correlations (blue). The four RNA polymerase II datasets are clustered together, as would
be expected.
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H1
H9
IMR90
Figure 3.1: Comparison of the correlation between the enrichment scores for three cell lines:
H1, H9 and IMR90. Data from H1 cell lines are shown along the yellow lines; H9 cell lines pink
lines and IMR90 along the green lines. Squares in dark red are highly correlated, with dark
blue negatively correlated.
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Figure 3.2: Comparison of the correlation between the enrichment scores for the H1 (yellow)
and H9 (green) cell lines. Squares in dark red are highly correlated, in dark blue negatively
correlated.
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Figure 3.3: Heatmap showing the correlation between the enrichment values for the histone
markers for the H1 human embryonic stem cell line. Histone modifications that occur are
marked as follows; histone H2a red, H2b yellow, H3 green and H4 blue. Histone modifications
that involve mono-methylation (Me1) are marked as light grey, bi-methylation (Me2) as medium
grey, tri-methylation (Me3) as dark grey and acetylation (Ac) as orange. Squares in dark red
are highly correlated, while those in dark blue are negatively correlated.
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Figure 3.4: Heatmap showing the correlation between the enrichment values for the tran-
scription factors for the H1 human embryonic stem cell line. Squares in dark red are highly
correlated, while those in dark blue are negatively correlated.
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3.3.2 LASSO regression
Linear regression was performed on the data for the H1 human embryonic stem cell line using
the LASSO predictor selection method with the aim of modelling RNA polymerase II binding.
Firstly this was done on the enrichment values (figure 3.5, table 3.4), and then on the log of
the enrichment values (figure 3.6, table 3.4).
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Figure 3.5: The linear models for the four H1 embryonic stem cell RNA Polymerase II datasets.
The actual data are the enrichment values for each gene for RNA polymerase II. The predicted
data are the enrichment data for all of the transcription factor and histone modification datasets,
scaled by the co-efficients determined by the LASSO regression.
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Figure 3.6: The log linear models for the four H1 embryonic stem cell RNA Polymerase II
datasets. The actual data are the logged enrichment values for each gene for RNA poly-
merase II. The predicted data are the logged enrichment data for all of the transcription factor
and histone modification datasets, scaled by the co-efficients determined by the LASSO re-
gression.
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Dataset R2 Number of predictors
used
Number of predictors
eliminated
s
SRR351568 0.751 43 4 1.41x10−5
SRR351569 0.794 35 12 1.90x10−5
SRR351787 0.727 40 7 2.12x10−5
SRR351788 0.741 44 3 7.76x10−6
SRR351568 log 0.817 40 7 7.70x10−6
SRR351569 log 0.843 42 5 3.61x10−6
SRR351787 log 0.797 37 10 1.05x10−5
SRR351788 log 0.791 46 1 1.08x10−6
Table 3.4: Summary of the LASSO models for the four RNA polymerase II datasets for the
enrichment values and logged enrichment values. s is the selection criterion determined by
cross-validation of the LASSO regression models.
The LASSO regression models for both the logged enrichment and non-logged enrichment
values were very good. The non-logged models have an R2 between 0.727 and 0.794 and
eliminate between 3-12 predictors. The logged models have an R2 between 0.791 and 0.843
and eliminate between 1 and 10 predictors. Overall, comparing the logged and non-logged
values, the logged values have a higher R2, though there is a difference between the number
of predictors used. It is likely that the increase in R2 when using the logged enrichment values
as using the logs ensures a more linear relationship between the data (table 3.4).
Dataset R2 Number of predictors
used
Number of predictors
eliminated
s
SRR351568 TF 0.720 23 0 0.0
SRR351569 TF 0.757 19 4 1.1x10−5
SRR351787 TF 0.693 22 1 3.15x10−6
SRR351788 TF 0.686 22 1 8.19x10−6
SRR351568 HM 0.683 23 1 2.89x10−6
SRR351569 HM 0.697 19 5 8.71x10−6
SRR351787 HM 0.647 23 1 3.70x10−6
SRR351788 HM 0.639 24 0 0.0
Table 3.5: Summary of the LASSO models for sub-sets of the four RNA polymerase II datasets
for the enrichment values and logged enrichment values. s is the selection criterion determined
by cross-validation of the LASSO regression models. TF: Transcription factors only. HM:
Histone Modifications only.
The logged enrichment datasets were then split into two groups: the histone modifications
and the transcription factors. Looking at the separate effects of the histone modifications and
transcription factors is the simplest way to look at how they affect RNA polymerase II binding
and how they act independently of each other. Comparing the R2 for the transcription factor-
or histone modification-only, the transcription-factor models have an R2 of between 0.686 and
0.757, while the histone modifications have an R2 of between 0.639 and 0.697. Overall, the
transcription factor-only models perform better than the histone modification-only models but
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they both eliminate a similar number of predictors in the optimal model. This is interesting
and a contrast to the results found in the previous chapter, where the histone modifications
alone produced a better model than using transcription factors alone or a mixed transcription
factor and histone modification model. For this data, the mixed transcription factor and histone
modification model produces a better model than using either of the sub-sets separately. With
the exception of one of the RNA polymerase II datasets used, the all-data model has a higher
R2 and uses fewer predictors. The only exception is the SRR351569 RNA polymerase II
dataset which eliminates five of the predictors for the histone modification-only sub-set, four of
the predictors for the transcription factor-only sub-set but only eliminates four of the datasets in
the logged enrichment value model for all of the data. For the non-logged all-data model of the
SRR351568 dataset however, 12 of the predictors have a co-efficient of 0 and are eliminated
from the model.
Looking more closely at the models and the elimination of predictors, it should be possible
to gain some insight for a mechanistic hypothesis of RNA polymerase II binding in human
embryonic stem cells. The overall view of the binding of RNA polymerase II is a lot less clear
from these models than for the mouse models in the previous chapter.
Taking all of the sub-sets of data, including the non-logged, logged, transcription factor-only
and histone modification-only models, there is little overlap between the predictors which are
selected out of the models (figure 3.7). For each of these sub-sets of data, there were no
occurrences where two sub-sets dropped the same predictor more than twice in each sub-set.
Only one predictor, USF-1, was dropped in more than two of the sub-sets, being left out of
two non-logged models, one log model and one transcription-factor only model. USF-1 is a
transcription factor that has been shown to bind to FOSL1, this elimination could be due to
its redundancy with this transcription factor. A comparison of the histone modification-only
with the log models show only a single overlap between the predictors that are eliminated:
H3K56ac. There is more coordination between the transcription factor-only and the log model
however, with three of the six markers that are selected out of the transcription factor-only
models also being selected out of the models for the same RNA polymerase II dataset in the
log models: GABP, USF-1 and p300. Overall there is little consistency between the sub-sets
of the data with few of the markers being selected out multiple times within multiple sub-sets
of the data.
Looking closer at each of the sub-sets, there is more consistency within the non-logged
and logged models than between them. This does not hold true for the histone modification-
only or transcription factor-only sub-sets of data though, here there are no markers selected
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568 569 787 788
568
log
569
log
787
log
788
log
568
TF
569
TF
787
TF
788
TF
568
HM
569
HM
787
HM
788
HM
H3K9me3 1 0 0 1 1 1 1 1 1 1 1 1
H3K4me1 1 1 1 1 1 1 1 1 1 0 1 1
H3K36me3 1 1 1 1 1 1 1 1 1 1 1 1
H2AK5ac 1 1 0 1 1 1 1 1 1 1 1 1
H3K4me2 1 1 1 1 1 1 1 1 1 1 1 1
H2BK120ac 1 0 1 0 1 0 1 1 1 1 1 1
H2BK12ac 0 0 0 1 1 1 1 1 1 1 0 1
H2BK15ac 1 1 1 1 1 1 1 1 1 1 1 1
H2BK20ac 1 1 1 1 1 1 1 1 1 1 1 1
H2BK5ac 1 1 1 1 1 1 1 1 1 1 1 1
H3K23me2 0 0 0 0 1 1 1 1 1 0 1 1
H3K27me3 1 1 1 1 1 1 1 1 1 1 1 1
H3K4me3 1 1 1 1 1 1 1 1 1 1 1 1
H3K79me1 1 1 1 1 1 1 1 1 0 0 1 1
H3K79me2 1 1 1 1 1 1 0 1 1 1 1 1
H3K9ac 1 1 1 1 1 1 1 1 1 1 1 1
H4K20me1 1 1 1 1 1 1 1 1 1 1 1 1
H4K5ac 1 1 1 1 1 1 1 1 1 1 1 1
H4K91ac 1 0 1 1 0 1 0 1 1 1 1 1
H3K27ac 1 1 1 1 1 1 1 1 1 1 1 1
H3K18ac 1 1 1 1 1 1 1 1 1 1 1 1
H3K23ac 1 1 1 1 1 1 1 1 1 0 1 1
H3K4ac 1 1 1 1 0 1 0 1 1 1 1 1
H3K56ac 1 1 1 1 0 1 1 1 1 0 1 1
HDAC2 1 0 1 1 0 0 0 1 1 1 1 1
NRSF 1 1 1 1 1 1 1 1 1 0 1 1
SP1 1 1 1 1 1 1 0 1 1 1 1 1
FOSL1 1 1 1 1 1 1 1 1 1 1 1 1
BCLIIA 1 1 1 1 1 1 0 1 1 0 1 1
SIX5 1 1 1 1 1 1 1 1 1 1 1 1
CTCF 1 1 1 1 1 1 1 1 1 1 1 1
GABP 1 1 1 1 1 0 1 1 1 0 1 1
SRF 1 0 1 1 1 1 1 1 1 1 1 1
USF-1 1 0 0 1 1 1 0 1 1 1 0 1
TCF12 1 1 0 1 0 1 1 1 1 1 1 1
Sin3AK-20 1 1 1 1 0 0 1 1 1 1 1 1
EGR-1 0 1 0 1 1 1 0 1 1 1 1 1
NANOG 0 0 1 0 1 1 1 1 1 1 1 0
POU5F1 1 1 1 1 0 1 0 1 1 1 1 1
TAF1 1 1 1 1 1 1 1 1 1 1 1 1
RAD21 1 1 1 1 1 1 1 0 1 1 1 1
TAF7 1 1 1 1 1 1 1 1 1 1 1 1
RXRA 1 0 1 1 1 1 1 1 1 1 1 1
ATF3 1 0 1 1 1 1 1 1 1 1 1 1
YY1-(sc-281) 1 0 1 1 1 1 1 1 1 1 1 1
J unD 1 1 1 1 1 1 1 1 1 1 1 1
p300 1 1 1 1 1 0 0 1 1 0 1 1
Figure 3.7: Heatmap showing the LASSO models for the four RNA polymerase II datasets.
Sections in blue indicate the marker was included in the optimal model: sections in red indicate
the marker was left out of the optimal model. The four RNA polymerase II datasets were
abbreviated to the last three numbers of their accession code. TF: Transcription factor-only
model. HM: Histone modification-only model.
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out in more than one RNA polymerase II dataset for the transcription factor-only sub-set of
data. Only a single predictor, H3K79Me1, is selected out from two models for the histone
modification-only sub-set of data. For the non-logged and logged sub-sets, there are many
more predictors that are selected out of multiple models. This consistency, along with more
predictors being selected out of the non-logged and logged models, indicates that the models
that encompass all of the data are more robust and reliable than the histone modification-only
and transcription factor-only models. This, coupled with the better R2 values across both of
the whole-data models and compared to the split models, increases the likelihood of this being
correct. For the non-logged models, there are four occurrences where a predictor is selected
out of two models: H3K9Me3, H2BK120ac, USF-1 and EGR-1. There are two occurrences
where a predictors is selected out of three models (H2BK12ac and Nanog) and a single case
where a predictor is selected out of all four models (H3K23Me2).
Particularly of note here are EGR-1 and Nanog. EGR-1 (Early Growth Response protein
1) is a regulator of, and required for, differentiation. EGR-1’s absence from the model is in-
teresting, but not surprising, as the genes it targets for transcription promote differentiation
and mitosis, both of which are suppressed in embryonic stem cells. Nanog, a protein that is
essential for self-renewal and maintenance of undifferentiation of embryonic stem cells is also
missing. The absence of the Nanog binding data from the majority of the non-logged-data
models is interesting because it is vital for the establishment of pluripotency. Since Nanog is
statistically redundant with the information contained in the other datasets, either its effect is
too small to see using the broad metric of the enrichment values or its effect is already ac-
counted for by the rest of the data. As Nanog is only needed to establish pluripotency, not
maintain it this could also explain this result.140 It is possible that the effect Nanog has on the
other markers in the model makes the data for the gene statistically redundant in the model.
For the logged models, there are five occurrences where predictors are selected out of
two models: H4K91ac, H3K4ac, Sin3AK-20, Pou5F1 and p300. There was also a single
case where a predictor was selected out of three models: HDAC2. There are two interesting
proteins that are not included in multiple of the logged-data models: Pou5F1 and Nanog.
Pou5F1 is an essential protein for the maintenance of pluripotency. As with Nanog for the
non-logged models, presumably the effect it has on RNA polymerase II binding is either lost
in the broad study or its effects are already accounted for by the other datasets. HDAC2 is a
protein responsible for binding the acetyl group to histones. HDAC2 is likely not included in the
model in these cases as the information in the HDAC2 dataset is contained in the datasets of
the acetylated histones.
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3.3.3 Discussion
The comparison of the H1, H9 and IMR90 human embryonic stem cell lines clearly shows that
it is not valid to use datasets from different cell lines with each other. While it may be possible
for some cell lines, ChIP-seq data is noisy already without potentially introducing biological
noise on top of the noise introduced by the techniques used.
Overall, the simple enrichment value metric, coupled with LASSO regression, results in ac-
curate models for predicting the binding of RNA polymerase II. The use of LASSO regression
to eliminate predictors from the models is effective and efficient. The best performing models
use all of the datasets and the log of the enrichment values. This contrasts with the previous
work where the optimal models were generated when only using histone modifications. This
is likely due to having a much larger amount of data available for the cell line. While there is
a large amount of statistical redundancy between the histone modification and transcription
factor data, each individually does contain information the other does not. This is reinforced
by the findings of Cheng and Gerstein, who found that the addition of histone modification
data to a transcription factor-only model or the addition or transcription factor data to a histone
modification-only model improved the amount of variance accounted for by the model by about
10%.76 A difference was also evident between the human data and the mouse macrophage
data; in the human data, the transcription factor models were better than the histone modi-
fication only models, whilst the reverse was true for the mouse macrophage models. Using
both the transcription factor and histone modification data not only results in better models for
the human embryonic stem cell data, but also produced models which eliminated the most
predictors. The comparison of the number of eliminated predictors in the all-data model to
the models using only transcription factor or histone modifications shows that there is a re-
dundancy between the information in the transcription factor data and the histone modification
data. This is in agreement with previous work by Cheng & Gerstein where it was also found
that transcription factor binding and histone modification data were statistically redundant in
mouse embryonic stem cells.75 This redundancy well less clear in the results of the previous
chapter. For the larger dataset of the human embryonic stem cell data, the redundancy be-
tween the transcription factor and histone modification data is more obvious but less abundant,
with many more datasets being eliminated from the final models.
As in the previous chapter, a direct comparison of the results between the models devel-
oped in this work and those of previous work by Cheng and Gerstein105 and Ouyang et al 74
is not entirely relevant due to the vastly different objectives of the methods. A comparison is
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still interesting however. Cheng and Gerstein were able to explain 72% of the variance in their
response variable using support vector regression on 12 transcription factors and 7 histone
modifications. Ouyang et al we able to explain 70% of the variance in their response variable
using principle component analysis on 12 transcription factors. Here, we explained 80% of
the variance in the RNA polymerase II binding data using LASSO regression on 23 transcrip-
tion factors and 24 histone modifications. While the model produced here does explain more
variance than the previous methods, it also has far more data available for training the mod-
els. While having more predictors almost always leads to better models, simply due to having
more data to optimise on, the LASSO regression eliminates any predictors that add no extra
information to the model, avoiding this over-fitting. While the purpose of the models differ, both
the results here and the results of Cheng and Gerstein highlight the statistical redundancy
between the transcription factor and histone modification data.
While the models themselves are good and provide a clear picture as to the general state of
redundancy between the transcription factors and histone modifications, the more fine-grained
picture of the mechanism of RNA polymerase II binding is less clear. Within the sub-sets of
data (all data non-logged, all data logged, transcription factor-only, histone modification-only)
there is little consensus between the RNA polymerase II datasets. The non-log and log models
both have similar levels of corroboration between the RNA polymerase II datasets. There
is, however, a large amount of variation between the sub-sets of data, with the transcription
factor-only and histone modification-only datasets having very little consensus between or
within themselves. This is most likely because the range of transcription factors and histone
modifications is fairly broad and all of the datasets have at least a small amount of unique
information. The increased number of predictors eliminated from the logged and non-logged
models is a strong indication of the redundancy between the transcription factor and histone
modification datasets. There is, however, little consensus in which predictors are eliminated
from these models. This is potentially due to the redundancy between the predictors and the
method in which the models are constructed. Predictors are eliminated in various models; this
is potentially due to the modelling taking alternative “kinks” in the path to the final model. The
selection of one predictor at a certain point will result in the elimination of others that have
redundancy with it, or combinations of predictors the model already contains.
Further development of this method would involve using interaction terms in the model. The
result would contain a multiplication of every combination of all the predictors, making it signif-
icantly more complicated, and also statistically impossible on smaller sets of data. The large
number of genes in our dataset makes the inclusion of the interaction terms possible while the
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LASSO regression method allows the elimination of unnecessary predictors and avoids over-
fitting. The methods used here are very broad. The enrichment metric used is very simple
and is measured over a section of DNA that is both large, relative to the size of transcription
factor binding sites, but also small compared to the potential spread of a histone modification.
The enrichment value has a huge potential for refinement, from the exclusion of genes and
accounting for the GC-content in the background calculation, to adding a term for long-range
interactions. The current method of using all of the genes as data points in generating the
linear models also means that the model will only be true for the general case and will be less
good for specific cases. Combining interaction terms with principle component analysis could
highlight some interesting combinations of genes responsible for different functions in the cell.
None of the current methods, including the one developed here, deal with the difficult prob-
lem of enhancer sites. The remote location of enhancer sites from the gene or genes they
regulate causes a massive problem in the prediction of gene regulatory mechanisms. It is not
currently possible to predict the location of enhancer sites not is it possible to identify what
genes they have an influence on. While the method of Ouyang et al accounts in some way
for distal transcription factor binding, it assumes the further from the genes transcription start
site the binding is, the less influence it has on the expression of the gene. This is not true in
the cases of enhancers. One of the best ways to improve these methods will be to work on
encompassing these remote, but highly influential, enhancer sites into the models.
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Chapter 4
Hot-Spot Prediction in
Protein-Protein Interfaces
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4.1 Introduction
Understanding, and being able to predict, protein-protein interactions will be essential for the
complete understanding of intra- and inter-cellular function, as well as elucidating the large
protein-interaction networks that are present in every cell. All proteins are involved in a protein-
protein interaction at some point between their translation and their degradation. Being able
to predict and understand how protein-protein interactions occur will add vastly to the knowl-
edge of how cells function as it will allow a better understanding of their precise function, and
movements and actions within a cell.
4.1.1 Properties of the Interface
Size and Shape
The size of the interface involved in protein-protein binding varies considerably depending on
the type of the interaction and the number of proteins involved. On average 12% of the sol-
vent accessible surface area of each monomer in a dimer is involved in the protein-protein
interface, rising to 17% of each monomer’s surface for trimers and 20% of the surface area
for each monomer for tetramers.188 The binding of proteins leads to an average loss of 5-
20% (∼780Å2) in solvent accessible surface area, 12% of the solvent accessible surface area
of each monomer in a dimer is involved in the protein-protein interface, rising to 17% of each
monomer’s surface for trimers and 20% of the surface area for each monomer for tetramers.188
The amount of solvent accessible surface area lost when two proteins bind is related to the
molecular weight of the proteins involved.189 Larger losses of solvent exposed surface area
leading to stronger interactions.189;190 The variability in the amount of solvent accessible sur-
face area lost is large, with some complexes, such as the superoxide dismutase dimer, losing
as little as 670Å2 SASA per protein monomer (Figure 4.1), and other complexes, such as cata-
lase forming a dimer, losing as much as 10,570Å2 SASA per protein monomer (Figure 4.1).191
While the size of the interface may vary between complexes, the shape often does not. Both
obligate (proteins that are always bound together) and non-obligate (proteins that are bind
transiently and are not always bound) protein-protein interfaces have been shown to be largely
flat,189 although non-obligate complex interfaces are less flat than obligates. Antibody-antigen
and enzyme-inhibitor complexes are likely to bind in the largest cleft on this surface.192
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Figure 4.1: A contrast between interface sizes for protein-protein interactions. The catalase
dimer (top, PDB ID 4CAT) loses 10,570Å2 of solvent accessible surface area when the two
protein chains form an interactions. The superoxide dismutase dimer (bottom, PDB ID 1SRD)
in comparison loses only 670Å2 of solvent accessible surface area when the two protein chains
interact. Overlapping van der Waals radii between the two chains are shown in red .191 Images
generated using the UCSF Chimera package .193
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Hydrophobicity
The hydrophobic effect drives a large number of the binding events in the cell and is a ma-
jor driving force in the formation of the phospholipid bilayer that surrounds cells. When a
hydrophobic molecule is introduced to bulk-water the polar water molecules re-arrange them-
selves to present as little polar surface to the molecule as possible, forming an organised sol-
vation shell around the molecule. When more than one hydrophobic molecule is present in the
system they cluster together so that as little surface as possible is exposed to the disorganised
bulk water. This minimises the number of water molecules in the organised solvation-shell
which leads to a rise in the entropy of the system. See figure 4.2 for a simple explanation
of this. Hydrophobicity is a significant influence on the characteristic of protein-protein inter-
Figure 4.2: When a hydrophobic molecule is in water, the water molecules form a cage around
it. This cage cause a reduction in the entropy of the system. When two molecules move
together, the cage that is formed around them is needs fewer water molecules than the two
individual cages, this raising the entropy of the system again. Image modified from Molecular
Modelling: Principles and Applications, Leach, 2001194
faces.195 The characteristics of a protein-protein interface vary significantly depending on the
proteins involved and hydrophobicity has a large influence on this. Interfaces between two
identical chains are homo-oligomers and are often obligate complexes, which are only con-
formationally stable when bound to each other. Interfaces between non-identical chains are
hetero-oligomers and are commonly non-obligates. Non-obligate protein-protein interactions
occur between proteins that are in the same location within the cell; their binding can be trig-
gered by a change in conditions, the association of a small molecule that induces binding, or
binding and un-binding can occur continuously.196 Due to the solvent-exposed nature of the
unbound proteins, the domains involved in binding must be independently stable in solution.
The independently-stable nature of non-obligate proteins contrasts with obligate binding pro-
teins, whose interface surfaces are often conformationally unstable in solution.188 The surface
of the protein-protein interface in obligate complexes is generally hydrophobic and provides the
driving force for the proteins to form a complex. When solvated the independent stability of the
non-obligate complexes means that the elucidation of crystal structures is often much easier
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for the unbound proteins than it is for bound complexes which are often only transiently stable.
The opposite is true for obligate complexes as the equilibrium of the bound and unbound com-
plex is so biased towards the bound complex that it is hard to isolate unbound proteins. The
difficulty in generating crystal structures of non-obligate complexes often means that the struc-
tures of the component proteins are obtained singly and must have their interacting surfaces
and binding conformations and surfaces predicted.
Amino acid composition
Protein-protein interfaces are generally more hydrophobic than the rest of the protein sur-
face.191 The residues present in a protein interface are similar to those that occur between
domains within a protein,188 with a bias towards aromatic and non-polar residues, and away
from small polar residues. The level of hydrophobicity is very interface-dependant. Obligate in-
terfaces on average have 65% non-polar, 22% polar and 13% charged residues,191 while non-
obligate interfaces have, on average, 55% non-polar, 25% polar and 20% charged residues
.190 This difference in hydrophobicity reflects the need for non-obligate protein interfaces to
be independently stable in solution. The number of non-polar residues on the surface of an
interface, and over the whole of an interacting protein, is no different to that of a small globular
protein that does not bind any proteins .197;198 This means that it is not possible to predict
whether a protein will interact or to identify a binding region simply by looking at the properties
of the residues that make up the surface of the protein.
4.1.2 Hot-Spots
The amount of energy that each residue involved in the protein-protein interface contributes
to the binding is not equal, with some residues contributing significantly more than others. It
was discovered that the mutation of two tryptophan residues to alanine resulted in the loss
of affinity of human growth hormone to human growth hormone binding protein .199 Hot-spot
residues are defined as residues whose mutation to alanine causes a severe (>2 kcal/mol as
quantitatively measures and defined by Bogan and Thorn, 1998) loss in binding free energy
for the complex.200
“O”-rings
Analysis of alanine scanning mutagenesis data has shown that a number of residues around
the hot-spot residues form “O”-rings. An “O”-ring is a sheath of amino-acid side chains that
84
exclude bulk solvent from the interaction formed by the hot-spot residue and the interacting
protein.200 It has been estimated that this brings about a doubling of the hydrophobic effect
on the residues inside the “O”-ring.201 Inside “O”-rings, hot-spot residues were found to be
enriched by a frequency of over 10%) in tryptophan, arginine and tyrosine, whilst generally
lacking (frequency in hot-spots under 3%) in leucine, methionine, serine, threonine and valine
residues. There is, however, no preference for any single property, such as charged residues
or hydrophobic residues, in the “O”-ring or the hot-spots.200 It has been postulated that these
residues are more frequent at hot-spots due to their ability to form multiple types of interaction,
such as the ability of tryptophan to be involved in aromatic pi-interactions, hydrogen bonds (as
a donor) and as a large aromatic surface .200 Several studies have highlighted the conservation
of the enriched residues within protein families.202–204 Multiple hot-spots can occur in a single
interface204 and they generally form clusters towards the center of the interface.203 Hot-spots
tend to couple with hot-spots from the interface surface of the binding protein.205
4.1.3 Experimental Analysis of Protein-Protein Interactions
Experimental prediction of hot-spots
Experimentally elucidating hot-spot residues in protein-protein interfaces currently involves a
difficult and expensive process of alanine-scanning mutagenesis. Alanine-scanning mutage-
nesis is involves replacing residues in one of the two interacting proteins with alanine. This
replacement leads to a loss of the side-chain of the original amino-acid and hence the loss
of any interactions it made with the partner protein. The change in binding energy between
the two proteins is then taken as the energy contribution that the mutated residue gives to the
protein-protein interaction .206 Although this is an effective method for establishing the binding
energy contribution from a side-chain, it does have problems. If the mutation of the amino-
acid effects the 3-dimensional structure of the protein, it can lead to changes in the interface
surface. These changes can cause the two proteins to stop their close interacting, artificially
inflating the calculated binding energy for the amino-acid.
4.1.4 Computational Approaches
Docking
Predicting the docking of two proteins is a complicated task that cannot be solved trivially. The
nearly infinite number of possible orientations the two proteins can potentially be in with each
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other means that a brute force approach is not viable to find the lowest energy conformation.
More complex methods are needed that use information about the proteins and about their
interfaces, thereby constraining the number of possible orientations for the two proteins. To
constrain the number of possible orientations we need to understand the amino-acid compo-
sition of the surfaces, how they may possibly interact and any distinctive features they may
contain.
Protein-Ligand Interaction Prediction
In predicting protein-ligand, and protein-protein, interactions there are generally two stages.
First, large numbers of orientations of the two molecules to be docked are sampled and a set
of potential “correct” orientations is gathered. The main challenge in this step is in developing
an approach to this problem that has this “correct” pose in the final set of orientations whilst not
being too computationally expensive. Sampling every possible orientation would be impossible
due to the infinite number of different poses that are possible. The second step is to identify
the “correct” pose from the subset of the possible poses obtained from the first phase.
Autodock207 is one of the most cited docking programs available and has been through
numerous iterations. Autodock uses genetic algorithms, based on evolutionary principles, to
generate the final set of docking orientations. Genetic algorithms are based on evolutionary
principles, in this case the arrangement of the two molecules is equivalent to a gene and the
coordinates of the atoms for each molecule is the phenotype. It uses the AMBER force field208
to calculate the interaction energy between the two molecules then assigns a “fitness” value
based on the energy. The “fitness” values determines the likelihood whether the orientation
will “survive” or “die”. Variation can be introduced as “mutations” or mimicking the crossover of
genes.
4.1.5 Binding Site Detection
Identifying binding sites is a difficult problem and there have been numerous approaches to
the task; geometry based, energy based and knowledge based methods. Being able to predict
the location at which a ligand binds to a protein is an essential first task in structure based drug
design.
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Geometry Based Approaches
Geometry based binding site detection methods approach the problem of identifying ligand
binding sites by analysing the 3-dimensional structure of the protein with the aim of detect-
ing the pockets in the surface of the protein. It has been shown that often, but not always,
the largest pocket in the surface of the protein is the ligand binding site.209 Methods such as
POCKET210 uses 3Å probes passed along each of the x , y and z axis. Pockets are identi-
fied where a period where the probes don’t overlap with the protein is surrounded by periods
where the probe overlaps with protein atoms. This method is highly dependent on the original
orientation of the protein on the axes. LIGSITE211 and Pocket Finder209 use a similar method
but pass the 3Å radius probe along the x , y , and z axis and also along cubic diagonals. This
reduces the effect that the original orientation has on the pockets that are detected.
Energy Based Approaches
Energy based approaches to binding site detection, such as GRID,212 approach the prob-
lem by estimating the interaction energy between a probe and the surface of the protein. Q-
SiteFinder209 uses the GRID force field to calculate the energy of a van der Waals probe with
the surface of the protein as it is passed along a grid. These interaction energies are then
spatially clustered to produce pockets. Whilst the geometry based methods tend to identify
the largest pocket as the ligand binding site, Q-SiteFinder is often able to identify the ligand
binding pockets when this isn’t the case.209
Knowledge Based Approaches
Knowledge based binding site detection methods approach the problem using biological infor-
mation not necessarily associated with the structure to identify potential binding sites. Some
methods, such as ConSurf,213 identify the ligand binding sites using sequence conservation.
This method works well for enzymes as the active site is often highly conserved between pro-
teins that bind the same ligand. If there are similar proteins with high-resolution structures,
determined by NMR or X-ray spectroscopy, it is possible to perform homology modeling to
identify conserved ligand binding sites.
All of these methods perform well when the structure of the ligand-bound protein is avail-
able. When the structure of the protein changes significantly when the ligand binds it is much
harder to identify the correct binding site from the unbound structure. None of these methods
perform well when trying to identify the ligand binding site is located in the interface between
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two proteins of a complex. The huge number of potential ligands can also pose a problem if
the ligand the protein binds is unknown.
4.1.6 Hot-spot prediction
The difficulty in predicting the hot-spot residues in a protein-protein interface is due to the
lack of defining features which would otherwise help to determine whether the target patch
of protein surface is involved in a protein-protein interface. Recently, it has been established
that desolvation and conservation are two of the most important properties of a protein-protein
interface. Cleft size and electrostatics, which are important when attempting to predict protein-
ligand interactions, are much less important for protein-protein interactions. The function of
the complex determines the effect each property has. For example, in enzyme-inhibitor com-
plexes, there is a larger influence from cleft size and electrostatics whereas only desolvation
is indicative of antibody-antigen interactions.214
Kortemme and Baker were one of the first to produce a method for predicting hot-spot
residues in 2002.215 They developed a computational alanine scanning method using free
energy calculations. Their free energy calculation includes terms for polar interactions, shape-
complementarity and a solvent interaction term which penalises interactions between hydropho-
bic residues and water. The change in binding free energy was calculated when each residue
of an interface was mutated to alanine and any residue with a change in binding free energy
above 1kcal/mol was identifies as a hot-spot residue.215
Li et al have worked to produce a hot-spot prediction method based on the number of
atoms of a residue involved in sidechain-sidechain contacts; the difference between the num-
ber of atoms involved in favourable and unfavourable contacts and the difference between
the number of favourable contacts and unfavourable contacts.201 Hot-spot residues frequently
have more atoms involved in sidechain-sidechain contacts, with a larger number of atoms in-
volved in favourable contacts and also have a larger total number of favourable contacts.201
Non-hot-spot residues have fewer atoms involved in sidechain-sidechain contacts, more atoms
involved in unfavourable contacts and more unfavourable contacts.201 When tested on homo-
dimers, a method based on predicting hot-spot residues using these factors performed sim-
ilarly to the energy based FOLDEF method,216 but better than the structure based method
PP_SITE217 and the alanine scanning based method of Kortemme et al.215 A problem with
using the method proposed by Li et al 201 is that it fails to distinguish between hetero-dimeric
complexes and crystal-packing artifacts produced by X-ray crystalography.201
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The majority of hot-spot prediction methods require a 3-dimensional structure of the tar-
get protein in order to analyse the shape and structure of the surface. A novel approach
has been taken by Grosdidier and Fernandez-Recio218 using Normalised Interface Propen-
sity (NIP) values. NIP values are generated for each residue in the protein from Free Fourier
Transform-based docking methods.219 Grosdidier and Fernandez-Recio ensured a robust NIP
value by use of low-energy orientations for each of the training set proteins used to generate
the NIP values. This enables the NIP-values to still function accurately in situations where
larger conformational changes occurred and when no near-native structures were generated
in the docking stage.218 In the author’s comparisons with well established methods such as
Robetta220 and Foldef216 the method performs comparably, although producing a substantially
lower sensitivity compared to Robetta; this is made up for by the flexibility of allowing the anal-
ysis of non-modeled proteins. Ofran and Rost221 have developed another non-3D method,
called ISIS, which is a neural network trained on all the interface residues in the Protein Data
Bank.222 ISIS produces low accuracy, low sensitivity and low specificity, because it was trained
on a large selection of hot-spot and non-hot-spot interface residues and is based on sequence
alone. This is likely because the amino acid sequence alone does not give information about
what residues are in close proximity in the 3-dimensional structure of the protein.221
4.1.7 InterbasePro
InterbasePro is a database of predicted protein-biomolecule interaction energies. These pre-
dicted energies are calculated using MultiDock and optimised for DNA/RNA-protein interac-
tions.223 MultiDock is a molecular mechanics-based algorithm originally designed for calcu-
lating stable conformations in protein-protein interfaces but has been used for the calculation
of the energy changes in the substitution of one amino acid to another in a protein-protein
interface.224
MultiDock uses iterative mean field optimisation; a repeated two-step approach to calcu-
lating the interaction energy between two amino acid residues in a protein-protein interface.
Firstly, each amino-acid side chain in the interface region has a set of conformational alterna-
tives, rotamers, based on a library of possible rotamers.225 Hydrogen atoms, not in the library,
are then added to the rotamers. Iterative mean field optimisation is then used to calculate an
energy for each possible rotamer and ranked by probability of occurrence. The next step is the
use of the top-ranked rotamers in a rigid body energy minimisation to reduce any unfavourable
interactions between the rotamer, the rotamers neighbouring amino acids and the amino acids
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on the partner protein. These two steps are then repeated until no more improvement can be
made for the intermolecular interaction energy.223 The molecular mechanics potential energy
function used by MultiDock is based on the AMBER force field.208 The components of this
force field and the molecular mechanics potential energy are described later.
Mean Field Optimisation
The mean field approach is used to calculate the potential energy for each rotamer.
E (i , k) = v(xik) + v(xik , xmc) +
N∑
i=1,j 6=1
kj∑
l=1
(CM(j , i)v(xik , xjl)) (4.1)
For a protein comprised of N amino acids, each with side chain i and ki possible side chain
rotamers, the potential of mean force, E (i , k), can be calculated. The first term, v(xik), is the
internal energy of the rotamer where xik is the coordinates of the atoms of rotamer k of residue
i . The second term, v(xik , xmc), is the interaction energy between the rotamer and atoms of
the main chain, where xmc is the coordinates of the protein main chain atoms. The final term is
the interaction energy between the rotamer and all the other rotamers of every other residue,
weighted by their probabilities. CM is a conformational matrix of size N by max(ki ).
CM(i , k) =
e−E(i ,k)/RT∑Ki
k=1 e
−E(i ,k)/RT (4.2)
With all the potentials acting on all Ki possible rotamers of the i th residue, the Boltzmann
principle can be used to calculate the probability of rotamer k, as in equation 4.2, where R
is the Boltzmann constant and T is the temperature. CM(i , k) can then be used in equation
4.1 and the process repeats until the values within the conformational matrix converge at a
minimum. This minimum is classed as when the root mean square of the deviation between
the current and previous iteration, as calculated in equation 4.3 is less than 1x10−4.
rms =
√√√√ N∑
i=1
Ki∑
k=1
(CM(i , k)− CMold(i , k))2 (4.3)
Rigid Body Minimisation
The rigid body docking stage of MultiDock is to reduce any unfavourable interactions between
the two binding proteins. For efficiency, only residues that have another β-carbon within 15Å of
their β-carbon had their energy minimised. For glycine, the distance from the α-carbon is used.
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The larger of the two proteins to be minimised is kept rigid and immobilised for the rigid body
minimisation while the other protein is moved and rotated to find the minimum intermolecular
energy. Steepest descent was used for the minimisation with a maximum rotation of 1◦ and
maximum translation of 0.3Å, finishing when the energy decrease obtained by the successive
minimisation steps falls below 1x10−6kcal/mol.
Molecular Mechanics Potential Energy Function
Molecular mechanic potential energy functions are a combination of empirical force field pa-
rameters and Newtonian mechanics that, given the coordinates of the atoms in a system, can
be used to calculate the potential energy of the system. The general equation for the potential
energy function is as described in equation 4.4.
E = Eelec + EvdW + Estretch + Eangle + Etorsion (4.4)
Where E is the potential energy function, Eelec is the energy from electrostatic effects, EvdW is
the energy from the van der Waals interactions, and Estretch, Eangle , and Etorsion are the energy
contributions from bond stretching, changes in bond angles and the dihedral angles/torsions
respectively.
Electrostatics
The electrostatics portion of the potential energy function is calculated using the Coulombic
interaction energy between two atoms, as described in equation 4.5.
Eelec = 332
(
qiqj
rij
)
(4.5)
qi and qj are the charges for atom i and j respectively. rij is the distance between i and j .  is
the dielectric constant and is used to account for the effect of highly charged environments. To
have the resulting value in units of kcal/mol, a scaling factor of 332 is used.
van Der Waals
The van der Waals portion of the potential energy function is described using the Lennard-
Jones potential (equation 4.6). This equation elegantly describes the manner in which at a
distance, the van der Waals effect is mildly attractive. This attraction increases until their
electron “clouds” begin to overlap, where upon the van der Waals effect becomes increasingly,
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and rapidly, more repulsive. The first term of equation 4.6 describes the repulsive component,
the second describes the attractive component.
EvdW = 
(σ
r
)12
−
(σ
r
)6
(4.6)
r is the distance between the two atoms, epsilon is the van der Waals well depth and σ is the
distance at which the atoms start repulsing each other, or the collision diameter.
Bond Stretching
The bond stretching term is the deviation from normal in the length of the bond. A lot of energy
is required to change the length of a bond and as such the deviations from the normal are very
small. This means that it is possible to approximate the energy using Hooke’s Law.
Estretch =
k
2
(l − l0)2 (4.7)
Where k is the propensity for stretching, l is the bond length, l0 is the bond length where the
energy is at the lowest. The term (l − l0) describes the deviation from the minimum energy.
Bond Angles
The bond angle term describes the energy involved in the angle between the atoms deviating
from the optimal angle. As with the bond stretching term, the variations in this value are small
and it can be approximated using Hooke’s Law, equation 4.8.
Eangle =
k
2
(θ − θ0)2 (4.8)
Where k is a constant describing the effects of changing the angle, θ is the angle, θ0 is the
angle where the energy is at a minimum and as such, (θ − θ0) describes the deviation of the
angle from the minimum.
Torsion Angles
The torsion angles refers to the rotation about the bond. The profile of this energy is periodic
in that it depends on the number of surrounding atoms and their locations. The energy of the
angle depends on how well the atoms around the bond fit into “slots” between the surrounding
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atoms.
Etorsion =
N∑
n=0
Vn
2
[1 + cos(nω − λ)] (4.9)
Where n is the number of energy minima in a 360◦ turn, λ identifies where in the turn the
minima occur and ω is the torsion angle. Vn describes the energy required to rotate the atoms
between the minima.
Hydrogen Bonding
The number of hydrogen bonds formed by a complex has been shown to correlate strongly
with the size of the interface197 but, on average, protein-protein interfaces contain about ten
hydrogen bonds.195;197 The number of hydrogen bonds, as well as their strength, is dependent
on the type of interaction. Enzyme-inhibitor complexes tend to form hydrogen bonds between
their backbone atoms across the interface due to their close proximity and the manner in which
they bind into a cleft, while antibody-antigen complexes tend to form more hydrogen bonds
between side-chain groups.195;197
4.1.8 CAPRI
The Critical Assessment of Prediction of Interactions (CAPRI) was initiated to provide a blind
test of current protein-protein interaction prediction methods with the aim of comparing the
effectiveness of current methods as well as encouraging development of new methods. The
test cases for the CAPRI tests were provided by experimental researchers who have elucidated
the 3-dimensional structures of proteins whose bound structure was previously unknown. The
aim is to predict the bound structure of the protein complex when given the structure of the
unbound components without knowing any information about the target proteins before hand.
CAPRI assesses all the residue-residue contacts between the two proteins as well as the
residues that contribute to each side of the interface. For each of the submitted models the
fractions of the native and non-native contacts in the predicted model, the root mean square
deviation of the backbone atoms of the ligand protein and the mis-rotation and alignment of
the ligand compared to the native conformation.226–228
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4.1.9 Computational Hot-Spot Prediction Methods
There are a few methods currently available for predicting potential hot-spot residues using
a variety of different methods. Foldef216 is one of the earliest computational methods for
predicting hot-spot residues and uses a full atomic description of the structure of the proteins
along with empirical data obtained from protein engineering experiments to predict hot-spot
residues. A full atomic description means that Foldef is able to predict the energy each residue
contributes to the protein-protein interface by calculating all of the forces that are applied to and
by each atom of the reside, and hence predict the influence the residue has on the interface.
The correlation between the predicted changes in Gibbs free energy when a residue is mutated
to alanine and the experimental values was 0.7, setting a high benchmark for future methods.
Robetta229 was also an early method for predicting hot-spot residues. Robetta uses a linear
combination of the Lennard-Jones potential, a solvation term, hydrogen-bonding term and a
term for rotamers. This method was able to identify 79% of hot-spots in their test dataset and
is still one of the better methods available. There have been more recent methods that have
been developed around an empirical model, such as the Hotpoint web-sever.230;231 Hotpoint
uses additional factors such as conservation, solvent accessible surface area and pair-wise
residue potentials to predict hot-spot residues. It has 70% accuracy rate while retaining a
precision of 64% which is impressive in this difficult field. A number of more recent methods
have been focused on using machine learning to identify the best features to use for predicting
hot-spot residues. MINERVA232 uses a support vector machine based on features such as
structure, sequence, molecular interactions and conservation along with a decision tree to
establish the best combination of features. MINERVA performs well, with a sensitivity of 0.44,
specificity of 0.9 and precision of 0.65. Xu et al. have developed a method using a semi-
supervised boosting support vector machine and using Random-Forests to select the features
and prevent the support vector machine from over-fitting.233 This method has a good recall of
0.77 but sacrifices precision (0.46) and specificity (0.6) to attain this.
All of the hot-spot prediction methods train and validate their results using data from ASEdb
and BIC. They also all suffer from the same problem in that there is a very little experimental
alanine-scanning mutagenesis data available. Both ASEdb and BIC are outdated, with more
data available in the literature than in these databases. Even including this additional data,
due to the cost, difficulty and time involved in performing alanine-scanning mutagenesis ex-
periments, there is still very little data available. The lack of data is especially problematic for
any methods using machine learning as it limits the amount of features that can be added be-
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fore statistical problems arise. It causes issues in the development of all methods though as it
limits the amount of data that methods can be tested and trained on and the types of complex
that methods can be tested against.
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4.2 Method
4.2.1 Adaptation of InterbasePro
InterbasePro is an energy-based method for predicting the interaction energy associated with
residues in the protein-protein interface. It contains interaction energy profiles for protein-
protein, protein-DNA and protein-RNA complex structures present in the Protein Databank.234
The interaction energies are calculated using a modified version of the protein-protein inter-
face refinement tool, Multidock. InterbasePro considers the contribution to binding from the
electrostatic and van der Waals interactions.235 The iterative mean field optimisation used in
MultiDock is not applied to InterbasePro as the conformations given in the PDB are used.
Rigid body minimisation is still used on the PDB to reduce unfavourable interactions. These
processes are repeated until the interaction energy, calculated using the AMBER force field208
cannot be improved any further.235
The calculation for the prediction of the binding energy of a residue using InterbasePro is
set out in Equation 4.10.
pE = aEvdw + bEele (4.10)
pE is the calculated contribution to binding the residue makes, a and b is a normalisation con-
stants, Evdw is the InterBasePro predicted contribution from van der Waals interactions and Eele
is the InterBasePro predicted contribution from electrostatics. The results from InterBasePro
were fitted to the experimental energies using a least squares linear model, as provided by the
statistical package R112, to give the coefficients a and b which scale the energetic contributions
to reduce the difference between experimental and calculated energies.
A desolvation factor was also added to InterbasePro in the form of the energy required
for the transfer of an amino acid from solvent water to octanol. This is representative of the
transition of an amino acid from the surface of a bound protein, where it is solvated in water, to
a bound state where it is surrounded by other amino acids. The values for the octanol-water
transfer are taken from Radzicka and Wolfenden236 and are detailed in Table 4.1. The des-
olvation factor was combined with the InterbasePro electrostatic and van der Waals predicted
values as set out in Equation 4.11.
pEtot = aEvwd + bEele + cEtotaldesolv (4.11)
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pEtot is the predicted contribution to binding the residue makes to the protein-protein interac-
tion. Evdw and Eele are the predicted contribution to binding from van der Waals interactions
and electrostatic interactions respectively. Etotaldesolv is the octanol-water transfer energy for
the residue as taken from Radzicka and Wolfenden.236 a, b and c are the coefficients provided
by a linear model which scaled the predicted data to best fit to the experimental results, as
calculated using the R statistical computing program.112
Amino Acid Octanol-water transfer energy / kcal/mol
Leucine 1.76
Isoleucine 2.04
Valine 1.18
Phenylalanine 2.09
Methionine 1.32
Tryptophan 2.51
Alanine 0.52
Glycine 0.00
Tyrosine 1.63
Threonine 0.27
Serine 0.04
Histidine 0.95
Glutamine -0.07
Lysine 0.08
Asparagine -0.01
Glutamic Acid -0.79
Arginine -1.32
Cystiene 0.00
Proline 0.00
Table 4.1: Octanol-water transfer energies236 used as solvation factors for InterbasePro.
4.2.2 Alanine Scanning Mutagenesis Dataset
Two datasets were used for comparing the InterBasePro predicted binding energies to exper-
imentally derived binding energies. The change in free energy when a residue of a protein-
protein interface is mutated from the wild-type to alanine is directly related to the dissociation
constant, shown by Equation 4.12.
∆G = −RT ln(Kd) (4.12)
∆G is the change in Gibbs free energy of the system, R is the universal gas constant, T
is the temperature and Kd is the dissociation constant of the two binding proteins. The link
between free energy and dissociation constant allows a comparison of the difference made
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in the binding affinity of two proteins when a residue is mutated to alanine and the energies
predicted by InterBasePro.
∆∆G = ∆G(wt) −∆G(mut) (4.13)
The change in binding energy (Equation 4.13) is calculated as the difference between the
Gibbs free energy for the wild type complex (∆G(wt)) and the mutated complex (∆G(mut)) Two
datasets of alanine scanning mutagenesis experimental data were compared to the InterBase-
Pro predicted energies. Firstly, the data for protein-protein interactions were used from the
Alanine Scanning Database (ASEdb).237 A summary of this dataset is detailed in table 4.2.
Protein Number of Mutations ∆∆G Standard Deviation(kcal/mol) Structure Resolution / Å
1A4Y 28 0.98 2.00
1AHW 8 1.42 3.00
1BRS 14 2.55 2.00
1BXI 28 1.41 2.05
1CBW 9 0.64 2.60
1DAN 65 0.65 2.00
1DFJ 9 1.66 2.50
1GC1 32 0.39 2.50
1JCK 10 0.86 3.50
1RHG 26 0.51 2.20
1VFB 29 0.99 1.80
2PTC 1 - 1.90
3HFM 16 2.2 3.00
Total 275 1.47 -
Table 4.2: A summary of the dataset used from the Alanine Scanning Experiment Database
(Thorn & Bogan, 2001)237
The second dataset was mined from the literature using only data from the primary publication
rather than databases such as ASEdb and the Binding Interface Database (BID,238), although
some data in these sources were not available from primary sources (table 4.3). Where there
is overlap between the data in ASEdb and the second dataset, the values have been re-
calculated from the primary publication rather than re-used from ASEdb.
The ASEdb data set comprises of 6 Enzyme-Inhibitor complex, 5 immune complexes and 2
“other” complexes (1 toxin/receptor complex and 1 growth factor complex). The alternative data
set comprises of 7 enzyme-inhibitor complexes, 7 immune complexes and 2 “other” complexes
(both protein/receptor complexes).
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Protein Number of Mutations ∆∆G std Dev(kcal/mol) Structure Resolution/Å Source
1A4Y 28 0.98 2.00 a
1BRS 16 2.37 2.00 b,c
1BXI 32 1.11 2.05 d
1CBW 10 0.56 2.60 e
1DAN 65 0.64 2.00 a
1DFJ 8 1.45 2.50 a
1DQJ 21 1.83 2.00 e
1FAK 39 0.82 2.10 e
1FCC 10 1.60 3.20 e
1GC1 30 0.44 2.50 f
1JCK 10 0.93 3.50 g
1JRH 17 0.94 2.80 e
1JTG 7 2.24 1.73 e
1KTZ 16 0.71 2.15 e
1VFB 29 0.99 1.80 a
3HFM 16 2.37 3.00 h
Total 354 0.65
Table 4.3: The alternative dataset for the comparison of InterbasePro predicted data to alanine
scanning mutagenesis data. a - (Thorn & Bogan, 2001),237 b - (Schreiber & Fersht, 1995)239,c
- (Schreiber & Fersht, 1993)240, d - (Wallis et al, 1998)241, e - (Fischer et al., 2003)238,f -
(Ashkenazi et al, 1990)242, g - (Leder et al, 1998)243, h - (Rajpal, Taylor, & Kirsch, 1998).244
4.2.3 Predicting Pockets and Atom Contact Counts
Q-Sitefinder is a method for predicting binding pockets on a protein surface.209 A grid with
a point separation of 0.9Å is built around the protein. The non-bonded interaction energy
is calculated using the GRID forcefield.212 Any grid point which is able to accommodate a
methyl probe without overlapping with any protein atoms and with an interaction energy below
-1.4 kcal/mol is retained. These points are spatially-clustered so that no probe is further than
1Å (for a grid with a separation of 0.9Å) center-to-center from the nearest grid point in the
same cluster. The interaction energy is then summed over the cluster and the total energy of
the grid points comprising the pocket is used to rank the pocket.
Once pockets are found using Q-Sitefinder on both proteins involved in an interaction, each
protein is assessed to identify residues of its binding partner within these predicted pockets.
Since protein-protein interactions do not normally bind in the largest cleft on the surface of the
proteins no discrimination was made based on the size of the pockets that were predicted. For
each of the occupied pockets, the corresponding scaled predicted energy from InterbasePro
was compared in two stages - first using the values for the energy, then, secondly, using the
rank of the pocket and the rank of the predicted energy.
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4.2.4 Atom Contact Data
For each residue of a pair of interacting proteins, its ’atomic interaction count’ was calculated
as the sum of the number of atoms within 6Å of each atom of the residue, as calculated in
equation 4.14
Ci =
∑
0···n
kn (4.14)
Ci is the total count for residue i, n is the atom in the current residue and kn is the number
of atoms from the opposing protein within 6Åfor the current atom (i.e., an atom count for all
atoms within the first shell of van der Waals contacting atoms).
A pseudo-alanine scanning count was established by only counting the number of atoms
from the partner protein that were within the threshold distance across the backbone atoms
of the amino acid and the β -carbon, mimicking the mutation of the residue to alanine (Figure
4.3). This pseudo-alanine scanning count was then subtracted from the total count to produce
a third metric corresponding to the number of interactions that are due to the R-group of the
residue, ignoring any interactions that result from the backbone atoms. Proteins that have a
loop buried into clefts of their partner protein are likely to have backbone atoms that come into
relatively close contact with atoms on the partner, but between which no forces or influence
are exerted. In the pseudo-alanine scanning count, glycine is ignored due to the fact it lacks a
β -carbon. The dataset used for this work was the Protein Docking Benchmark 3.0.245
Figure 4.3: For each atom in a residue, any atoms of the opposing protein chain within 6Å
are counted and regarded as having an interaction. A pseudo-alanine scan is performed by
counting the number of interactions that are lost if the R-group was removed. In this case 4 of
the possible 7 interactions are below the 6Å threshold.
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4.3 Results & Discussion
4.3.1 Comparison of Calculations from InterBasePro with Experimental
Results from ASEdb
Comparing the values of InterBasePro to the experimental data from ASEdb shows a signif-
icant difference between the predicted and experimental values. While for some complexes
there is enough correlation to indicate that there is a relationship between the experimental
energies and the computationally predicted ones, there are other complexes that indicate the
opposite is true (Table 4.4). 1RHG and 1DAN are two complexes for which the correlation be-
tween the experimental and computational data is especially poor. 1RHG has a correlation co-
efficient of 0.02 and 0.05 for linear model scaled and unscaled correlations, respectively. 1DAN
has a correlation coefficient of 0.15 and 0.17 for scaled and unscaled correlations respectively.
For both of these complexes, the correlation coefficient implies that there is not a strong con-
nection between the hot-spot residues as indicated by the experimental data and those that are
predicted to have significant binding energies by InterBasePro. Two of the complexes where
there does appear to be a connection between the experimental and computational binding
energies are 1A4Y and 1VFB. 1A4Y has correlation co-efficients between the two methods of
0.47 and 0.48 for unscaled and scaled values respectively. 1VFB has correlation coefficients
between the two methods of 0.50 and 0.51 for unscaled and scaled values respectively. These
high correlation coefficients shows that there is indeed a connection between the alanine scan-
ning experimental data and the values that were predicted by InterBasePro. The p-values for
these complexes indicate that these results are likely to not be due to chance with values of
4x10−5 and 1x10−5 for 1A4Y and 1VFB respectively. Interestingly, the complexes where the
correlation was strongest had the least improvement when they were scaled using the linear
model. This is most likely because they were already close in value so the scaling had very
little to shift in values, making its effect smaller than on the complexes where the correlation
was poor, and there was greater scope for changing the predicted value to come more into
line with the experimental results. The graph showing the experimental results from ASEdb
and the predicted results from InterBasePro shows the correlation between the two methods
(Figure 4.4). The overall correlation between the experimental data from ASEdb and the pre-
dicted results is 0.29 for both the unscaled and scaled values from InterBasePro. Scaling
these results by the van der Waals and electrostatic energies from InterBasePro using a lin-
ear model had very little effect on the correlation between the experimental and computational
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results. This low overall correlation is evident from the scattering of points in Figure 4.4. The
graph also shows the number of true positive results (TP, points with high experimental energy
and high predicted binding energy), true negative results (TN, points with low experimental
and low predicted binding energies), false positive results (FP, points with low experimental
but high predicted energies) and false negative results (FN, points with high experiential but
low predicted energy). The cut-offs for a residue to be classed as a hotspot or not were 2
kcal/mol for the experimental energies, as used by Bogan and Thorn,200 and 1 kcal/mol for the
predicted energies. While there are similar numbers of true positive results and false positive
results (Table 4.6) (top right and bottom right quadrants of the graph respectively), there are
significantly more false positive results (top left quadrant of the graph) than either of these.
There are, however, a very large number of true negative results (bottom left quadrant of the
graph) where both the experimental and computational methods gave the residues low bind-
ing energies. This large number of true negatives is expected as non-hot-spot residues occur
more frequently than hot-spot residues though being able to identify reliably what residues are
not hot-spots can be useful.
PDBID R2 Scaled R2 Number of Mutations p Value (scaled)
1A4Y 0.47 0.48 28 0.00004
1AHW 0.06 0.33 8 0.13690
1BRS 0.42 0.42 14 0.01178
1BXI 0.36 0.50 28 0.00002
1CBW 0.00 0.37 9 0.08325
1DAN 0.15 0.17 65 0.00076
1DFJ 0.00 0.33 9 0.10340
1GC1 0.13 0.21 32 0.00889
1JCK 0.15 0.17 10 0.23280
1RHG 0.02 0.05 26 0.26050
1VFB 0.50 0.51 29 0.00001
3HFM 0.22 0.27 16 0.04746
All 0.29 0.29 274 <0.00001
Table 4.4: Correlation coefficients for the comparison of InterBasePro predicted changes in
binding energy with the alanine scanning mutagenesis data from ASEdb.
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Figure 4.4: A comparison of the experimental alanine scanning ∆∆G from ASEdb and pre-
dicted ∆∆G from InterBasePro, scaled by electrostatics and van der Waals forces using a
linear model.
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4.3.2 Comparison of Calculations from InterBasePro with Experimental
Results from the Second Dataset
As with the comparison of the ASEdb experimental results with the InterBasePro predicted
energies, the correlation between the experimental data mined from the literature and the
InterBasePro predicted energies are low (Table 4.5). The data mined from the literature is
more comprehensive than the data from ASEdb. The correlation coefficient for the unscaled
and scaled values is lower for the comparison of the mined-dataset with InterBasePro than
that for the comparison on ASEdb and InterBasePro; 0.20 and 0.29 respectively.
PDB R2 Scaled R2 Number of Mutations p-value (scaled)
1A4Y 0.48 0.48 28 0.0002
1BRS 0.43 0.43 16 0.0200
1BXI 0.02 0.12 32 0.1600
1CBW 0.48 0.64 10 0.0300
1DAN 0.22 0.28 65 <0.0001
1DFJ 0.05 0.31 8 0.3900
1DQJ 0.15 0.23 21 0.0900
1FAK 0.34 0.36 39 0.0002
1FCC 0.38 0.66 10 0.0200
1GC1 0.10 0.14 30 0.1300
1JCK 0.11 0.21 10 0.4500
1JRH 0.12 0.17 17 0.2800
1JTG 0.11 0.48 7 0.2600
1KTZ 0.23 0.81 16 <0.00001
1VFB 0.54 0.55 29 <0.00001
3HFM 0.20 0.22 16 0.1900
ALL 0.20 0.20 354 <0.0001
Table 4.5: Correlation co-efficients for the comparison of InterBasePro predicted changes in
binding energy with the experimental alanine scanning gathered from the literature.
For the mined-dataset, as with the ASEdb dataset, there are some complexes for which
InterBasePro predicts the binding energy of the residues well, and some where it performs
poorly. The correlation coefficients for 1CBW and 1FCC are good, especially when the elec-
trostatic and van der Waals forces are scaled using a linear model; both reaching a correlation
coefficient of over 0.6. There are several complexes, however, where the method performs less
well. As in the previous graph, Figure 4.5 shows the extent of the poor correlation between the
literature sourced dataset and InterBasePro. The number of true positives (top right quadrant),
false positives (bottom right quadrant) and false negatives (top left quadrant) are about similar
and the true negatives vastly out number all of these (Table 4.6).
The sensitivity and specificity values in Table 4.6 reinforce the idea that van der Waals
and electrostatics interactions are not effective at predicting if a residue is a hotspot, with
104
InterBasePro having a sensitivity of about 50% for both data sets. The high specificities, 0.92
(ASEdb) and 0.88 (all data), however, show that InterBasePro is an very effective predictor of
which residues are not hot-spot residues.
Figure 4.5: A comparison of the experimental alanine scanning ∆∆G mined from the literature
and predicted ∆∆G from InterBasePro, scaled by electrostatics and van der Waals forces
using a linear model.
ASEdb Alternative
True Positives 20 33
False Positives 31 46
False Negatives 17 34
True Negatives 205 240
Sensitivity 0.54 0.49
Specificity 0.92 0.88
Table 4.6: sensitivity and specificity for the linear model Scaled predicted values from Inter-
BasePro compared with the ASEdb and alternative experimental data sets. The cut-off for
being positive values for the experimental data is 2 kcal/mol and for the predicted values is 1
kcal/mol.
4.3.3 Adapting InterbasePro
A simple desolvation factor was introduced into InterbasePro to try to take into account the
effects of desolvation on the stability of a protein-protein interaction. The ability to account
105
PDB InterbasePro R2 p-value Octanol R2 p value Octanol
1A4Y 0.4960 0.0001 0.0228 0.4430
1AHW 0.0041 0.0101 0.2790 0.1790
1BRS 0.4360 0.0005 0.0101 0.733
1BXI 0.3790 0.7380 0.1020 0.0971
1CBW 0.0170 0.0039 0.0173 0.7360
1DAN 0.1250 0.1430 0.0158 0.3190
1GC1 0.0701 0.8430 0.0000 0.9920
1JCK 0.0522 0.2640 0.1290 0.3090
1RHG 0.0515 0.2460 0.0649 0.2090
1VFB 0.4210 0.0001 0.0017 0.8310
3HFM 0.1210 0.1870 0.0009 0.9140
All 0.2280 <2.20x10−16 0.0047 0.2650
Enzyme/Inhibitor 0.3010 <2.2x10−16 0.0016 0.5480
Immune 0.0794 0.1070 0.0098 0.5790
Table 4.7: Correlation coefficients for the comparison of the predicted energies from Interbase-
Pro and the experimental energies of ASEdb.237 InterbasePro R2 is the correlations comparing
InterbasePro to the experimental data while Octanol R2 refers to the data from InterbasePro
with an extra octanol-water transfer energy component added to act as a solvation factor.
for the effect of solvation is important as it is a significant contributing factor in the formation
of protein-protein interactions and the “O”-rings are thought to exclude the solvent from the
hot-spot residues.200 Using the calculated energy for the transition of an amino acid from wa-
ter to octanol is relatively similar to the transition of an amino acid from a solvated, unbound
state in water to a bound state in the mixed hydrophobic/hydrophilic environment of the pro-
tein interior.246;247 Combining a simple scaled octanol-water solvation factor with the energies
predicted by InterbasePro causes an overall decline in the correlation between the predicted
and experimental energies (R2 = 0.0047, table 4.7). The addition of a desolvation potential
does have a positive effect on the correlation coefficients for some proteins, 1AHW and 1JCK
in particular, but the p-values for these proteins show the results are not significant (p-value >
0.005). A more complex, atom-by-atom solvation potential would more likely be representative
of the effect of desolvation of residues as they go from the unbound to the bound state. Such
a method based on the work of Wesson and Eisenberg could be implemented248; a solvation
factor based on the loss or gain of accessible surface area for each type of atom rather than,
as used here, a single value used for each amino acid regardless of its exposure to the sol-
vent would more accurately reflect the influence of solvation. InterbasePro is an energy based
method that encompasses electrostatics and van der Waals terms in the prediction of binding
energies for each residue in a protein. Comparing the predicted energies from InterbasePro to
the experimental data from ASEdb in Table 2 shows poor correlation (R2 = 0.228). Figure 4.6
and 4.7 show comparison of the experimental energies and the predicted energies for proteins
in the ASEdb. There are a large number of residues with high experimental energies but with
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low predicted energies. There are also a large number of residues with a low experimental
energy but high predicted energy. There are very few residues where both the experimental
energy and the predicted energy were high. This lack of correlation between the experimental
and predicted energies could be due to the lack of a solvation factor being included in the pre-
diction of the energy. A potential flaw in the experimental data is that the change in the binding
energy recorded could be due to disruption of the 3-dimensional structure of the protein, po-
tentially causing it to unfold or take on another conformation. If the mutation of a residue to
alanine results in a conformational change in the protein it can lead to a large change in binding
energy, regardless of whether the residue was involved in the protein-protein interaction or not.
One approach could be to investigate the interactions of side chains with the side chains and
backbones of the residues surrounding it on the same protein chain. The more interactions
that are lost between the mutated residue and the backbone structure of the partner protein
the more likely it is that the mutation disrupts the conformation of the protein.
Figure 4.6: Comparison of the experimental alanine scanning mutagenesis data from
ASEdb237 and predicted energies calculated by InterbasePro. Points are labeled with their
respective 1-letter amino-acid code.
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Figure 4.7: Comparison of the experimental alanine scanning mutagenesis data from
ASEdb237 and unscaled predicted energies calculated by InterbasePro with an added des-
olvation term based on the octanol-water transfer energy of amino-acids.236 Points are labeled
with their respective 1-letter amino-acid code.
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4.3.4 Atom Contact Data
The atom contact data (Table 4.8) show a positive correlation between the number of interac-
tions and the experimental change in free energy when the residue is mutated to alanine in
alanine-scanning mutagenesis experiments. The pseudo-alanine scan count is show relative
to the experimental energy change in Figure 4.8. The overall trend is that as the number of
interactions made between a residue and the opposing protein increases, so the higher the
change in experimental free energy when the residue is mutated to alanine. Three proteins
Total Total p-value Diff. R2 Diff. p-value
1A4Y 0.226 0.0026 0.158 0.0134
1AHW 0.432 0.0147 0.746 0.0001
1BRS 0.255 0.0045 0.433 0.0001
1BXI 0.239 0.1046 0.321 0.0546
1CBW 0.238 0.0401 0.191 0.0696
1DAN 0.044 0.1955 0.021 0.3744
1GC1 0.042 0.4616 0.012 0.6960
1JCK 0.371 0.0000 0.054 0.1287
1RHG 0.005 0.6899 0.000 0.9633
1VFB 0.408 0.0010 0.458 0.0004
3HFM 0.115 0.1801 0.199 0.1101
3HHR 0.344 1.92x10−9 0.255 5.35x10−7
All 0.081 2.04x10−8 0.055 4.25x10−6
Enzyme/Inhibitor 0.249 4.41x10−4 0.254 2.22x10−16
Immune 0.152 2.60x10−4 0.161 2.29x10−4
Without Outliers 0.236 2.20x10−16 0.238 2.20x10−16
Table 4.8: Correlation coefficients for the atom count data. Total is the correlation coefficient
when regarding all the atoms in each residue. Diff. R2 and Diff. p-value are the difference cor-
relation and the p-value for the difference between the number of interactions made between
the whole of a residue and the partner protein and the number of interactions made by the
backbone atoms and the β -carbon. The outliers removed in the “without outliers” data are
1RHG and 1DAN.
disobey this trend: 1RHG, 1GC1 and 1DAN. Removing these proteins from the calculation of
the total Pearson’s correlation coefficient calculation has a positive effect on the overall corre-
lation due to the outlier nature of the results for these two proteins. Withdrawing these proteins
from the calculation increases the total correlation coefficient from 0.081 to 0.236 and the
pseudo-alanine scanning correlation coefficient from 0.055 to 0.238. The extremely low cor-
relation coefficients for 1RHG (R2=0.005, p-value=0.6899), 1GC1 (R2=0.042, p-value=0.4616
and 1DAN (R2=0.044, p-value=0.1955) are due to a few residues which have a massive num-
ber of contacts with the partner protein, far more than any other residue in the dataset, which
also have a small experimental energy change.
Overall the correlation coefficients show some agreement between the number of interact-
ing atoms and the energy changes produced by mutation to alanine. Some proteins, such
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Figure 4.8: Comparison of the atom contact count lost when a residue is mutated to alanine
and the experimental energies from ASEdb.237 coloured by protein
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as 1AHW, 1VFB, 1JCK and 3HHR, show significant correlation and p-values. While they are
still weak correlations they show the potential in this very simple method. Within the proteins
that for which the method functions well, there is a large variation in how effective the method
is between the total counts and the pseudo-alanine scanning count. 1JCK has a reasonable
correlation for the total count data, R2=0.371, but performs poorly, R2=0.054, for the pseudo-
alanine scanning. This difference is due to the close proximity of the backbone of the two
bonding chains.
Comparing the correlations for the data from enzyme-inhibitor complexes and the systems
involved in immune response shows that this method is more reliable for enzyme-inhibitor
complexes than immune complexes. This is most likely due to the weaker, more transient, and
generally more distant binding that occurs in antibody-antigen binding.
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4.4 Conclusions
All the results comparing the predicted results of InterBasePro with the experimental alanine
scanning results of ASEdb, as well as the data mined from the literature, show that the ability
of InterBasePro to predict which residues in a protein’s surface are hot-spots is poor. The
comparison of the predicted energies from InterBasePro, whether scaled using a linear model
or not, had a correlation coefficient of 0.29. The comparison of the predicted energies of
InterBasePro with experimental energies mined from the literature has a correlation coefficient
of 0.2. While generally poor, InterBasePro performs well for some complexes. What the results
also show is that InterBasePro is very effective at predicting which residues are not hot-spots.
This could mean that, although InterBasePro alone would not be effective at predicting which
residues are hot-spots in the general case, combined with further methods or factors, it could
be used to predict hot-spots. The use of all the data together for the model is likely not the
best way to approach the problem of predicting hot-spot residues. With extra information about
the function or type of complex the target proteins are it may be possible to tailor the methods
used to predict hot-spot residues.
Compared to Foldef and Robetta, both the fitted InterbasePro model and InterbasePro
with a solvation term performed poorly. On data from ASEdb, Foldef obtained a correlation
coefficient of 0.7.216 This is far in excess of the 0.2 and 0.004 for the InterbasePro and Inter-
basePro with solvation term models, respectively. In comparison to Robetta,220 again, both
methods used here performed worse, with Robetta being able to identify a far higher propor-
tion of the true-positive results than both InterbasePro and when InterbasePro is combined
with a solvation term. The differences between the prediction accuracy of the InterbasePro-
based methods and that of Foldef and Robetta is likely due the development process that
InterbasePro has undergone. Originally, InterbasePro was designed for predicting protein-
DNA interactions, despite the method it is based on, MultiDock, being designed for predicting
protein-protein interactions. The weightings of the energy terms were changed to optimise the
method for protein-DNA interactions, with more emphasis being placed on electrostatic effects.
While InterbasePro is not specific to protein-DNA interactions, the results here show that it has
lost the predictive power of its underlying method when re-applied to hot-spot prediction. In
comparison, Foldef and Robetta were both designed purely for predicting hot-spots in protein-
protein interactions. While the theory behind the solvation term used is logical, in actuality the
mechanisms behind solvation are far more complex than the assumptions in using just these
solvation terms. The decrease of the predictive power of the method when the solvation term
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is used in conjunction with the InterbasePro terms is likely due to the compound effects of the
design of InterbasePro with the simplistic assumptions made in the use of such a simple solva-
tion term. Though disappointing, predicting hot-spot interactions is a difficult task and requires
many rounds of iterative improvement on the methods used. Like InterbasePro, both Robetta
and Foldef use computation descriptions of the atomic interactions between all the atoms of
the residues of the protein, highlighting that InterbasePro could potentially be improved in it’s
ability to predict hot-spot residues. While the correlation between InterbasePro and the exper-
imental results is low, it is positive. This slight correlation does mean that it could potential be
combined with other metrics, such as the atom count method developed here, to improve on
its results.
The electrostatic and van der Waals interactions from InterBasePro are not predictive for
which residues are hot-spots but can be effective are predicting which residues are not hot-
spots. This is in agreement with previous work done by Burgoyne and Jackson214 which
shows that the only surface property that is consistently predictive of a protein-protein binding
region is the ease of cleft desolvation. Electrostatics, van der Waals, desolvation and surface
conservation showed little predictive power for whether a region of a protein’s surface was and
interface region. A potential future direction that will enable InterBasePro to act as an effective
hot-spot prediction method will be the introduction of a desolvation factor into the prediction
of energies. An atom-by-atom desolvation factor will potentially enable InterBasePro, after
filtering unlikely hot-spots residues, to filter and separate the true positive and false positive
results.
A significant problem in this area is the lack of experimental alanine-scanning mutagenesis
experimental data. Alanine-scanning mutagenesis is a complicated and time-consuming tech-
nique and, despite the wealth of information it provides, it is not often undertaken. Although
ASEdb is a good resource for this data, it is slowly becoming out-dated and not all of the data
appears to be available in the literature, having been uploaded by individual researchers. The
alternative data set produced from literature searching is far from ideal, having significant over-
lap with the data from ASEdb, albeit with values calculated independently from the literature
where needed, with neither data set being extensive. The small amount of data available will
potentially lead to a very narrow view of hot-spot properties and complicate the training of any
methods produced. More data would also give a better comparison between the different types
on complex and allow a more tailored approach to the problem, with adjusted calculations for
different complex types or functions.
As computing power increases in the future, it may well become possible to do full free-
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energy calculations on protein-protein interactions. At the current time it is still very compu-
tationally expensive to do these calculations in full for large scale systems. As the available
processing power increases it may well be possible to, given some assumptions to simplify
calculations and potentially using rigid-body modeling, to reduce the computation time needed
to a level where these complexes are able to be modeled.
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Chapter 5
Summary
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The initial chapter of this work establishes the use of a simple metric and linear regression
to model the binding of RNA polymerase II. The simple metric, based on the enrichment of
reads over the promoter and gene region compared to a background value, was used in all
of the models in the first two chapters. Initially this method was applied to a set of 5 tran-
scription factors and 4 histone modifications from mouse macrophage cells. The models pro-
duced showed a distinct redundancy between the histone modification and transcription factor
datasets. The best model only used 3 histone modification datasets to model RNA polymerase
II data and was able to explain 78% variance in the RNA polymerase II data. An investigation of
the genes with the largest and smallest residues showed no over-representation in genes spe-
cific to macrophage cells. A comparison between the histone modification-only model and the
next best model, which used 3 histone modifications and 3 transcription factors, was done to in-
vestigate the effect the transcription factors had on the models. By removing each transcription
factor, and every combination of the transcription factors, and comparing the resulting model
with the model using the 3 histone modifications and 3 transcription factors, it was possible to
look at which genes were affected most by the transcription factor/s in question. Analysis of
these most and least affected genes again showed no pattern in genes or over-representation
in macrophage specific genes.
By validating this method on the small set of data for mouse macrophage cells it allows
us to apply it to a larger dataset. A set of 47 ChIP-seq datasets from human embryonic stem
cells from the ENCODE project was used in the subsequent investigation; the datasets were
for 23 transcription factors and 24 histone modifications. Due to the large number of predictors
available, standard linear regression was not possible. LASSO regression was used to elimi-
nate predictors that contributed no extra information to the model. The resulting models varied
greatly in the numbers of predictors that were used in the model for each RNA polymerase II
dataset, with between 1 and 10 predictors being eliminated in each log-enrichment model. The
log-enrichment models performed the best and were able to explain between 79-84% of the
variance in the RNA polymerase II datasets. The statistical redundancy between the transcrip-
tion factor data and the histone modification data was especially clear from these models. The
histone modification-only and the transcription factor-only models eliminated between 0 and 5
predictors while the models that had all of the datasets available eliminated far more predictors,
up to 12. Models were produced for the 4 RNA polymerase II datasets. There was little con-
sensus between the predictors used for each of the models produced, most likely due to slight
variations in the RNA polymerase II datasets leading to different predictors being incorporated
into the model and ultimately a different set of predictors being used for the final models. This
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is unsurprising, the simple enrichment metric used along side the linear regression doesn’t
account for interactions between the different predictors. Further development of this method
would be to construct the models around interaction terms between every combination of the
predictors or to move away from using linear regression.
Previously, Ouyang et al used principle component analysis on 12 transcription factors to
explain 70% of the variance of micro-array expression data.74 Cheng and Gerstein have simi-
larly used support vector regression on a set of 12 transcription factors and 7 histone modifica-
tions to explain 72% of the variance in their expression data.105 The enrichment metric-based
method developed here is an improvement on these previous methods; the standard linear
regression explaining 78% of the variance of the RNA polymerase II binding data and the
LASSO regression explaining ∼80% of the variance. While the effectiveness of the methods
vary, the statistical redundancy between the transcription factor and histone modification data
that Cheng and Gerstein highlight can be seen in the results of the methods developed here,
especially the results of the LASSO regression on the human embryonic stem cell data.
The final chapter of this work was working on the difficult task of predicting hot-spots
in protein-protein interactions. InterBasePro is a previously-developed database of protein-
biomolecule interaction energies. This work focused on applying the information contained in
InterBasePro to the prediction of hot-spot residues in protein-protein interactions. Firstly, Inter-
BasePro was scaled using linear models to investigate the relationship it has to experimental
alanine scanning mutagenesis data. This data was obtained first from the ASEdb237 resource
and then a new dataset was sourced directly from the literature. When compared to both
datasets, InterBasePro performed poorly, with correlations of 0.29 and 0.22 when compared
to the ASEdb and the alternative data respectively. A desolvation factor was then added to
the InterBasePro data to try and account for a major effect on protein-protein interactions. The
addition of this term decreased the correlation between the InterBasePro data and the experi-
mental data to 0.0047. Compared to previous methods such as Foldef216 and Robetta220 the
methods developed here perform poorly, despite Foldef, Robetta and InterBasePro all using
computational descriptions of atomic interactions. While InterBasePro has a poor correlation
with the experimental data, the correlation it does have means it could potentially be a base
on which to develop further methods. While alone they would not be useful for predicting
protein-protein interaction hot-spot residues, they do show slight potential and could provide a
base upon which further methods could be based. A final investigation was made into using
the number of close atomic contacts each residue in a protein-protein interface has with its
partner proteins atoms. When compared to the experimental data, the Atom Contact data had
117
a correlation of 0.08. The correlation with the experimental data was vastly increased, how-
ever, when the experimental data was split into subsets based on the function of the proteins.
Enzyme/Inhibitor complex data had a correlation of 0.25 with the Atom Contact data. Despite
this poor correlation, and as with the results of using InterBasePro, the Atom Contact method
could provide a base on which to develop further methods. A large problem in the develop-
ment of methods to predict hot-spot residues is the lack of up-to-date sources of experimental
alanine-scanning mutagenesis data. While ASEdb and BID238 are the standards on which
methods are tested, they lack much of the more recently released data. While progress has
been made here into gathering some of this data from the literature, a large scale approach to
this would be beneficial to the field.
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